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ABSTRACT 
Introduction 
Folic acid supplementation in the periconceptional period is associated with reduced risk of 
neural tube defects. But most supplementation happens after the desirable period, having the 
supplementation some limitations in the prevention of neural tube defects, contrary to 
fortification. After an initial enthusiasm regarding folic acid fortification, new concerns raised in 
relation to potential adverse effects of fortification and supplementation of high doses of folic 
acid, namely in pregnancy outcomes, early and later in life, both in mother and child. 
In what concerns to diet, it has been shown that dietary patterns and the method of cooking 
have a clearly significant role in population folate intake, being a “healthy diet” more rich in this 
nutrient. 
From this state of the art, some questions deserve clarification such as: What are the 
recommendations in many countries worldwide concerning folic acid in the periconceptional 
period?  Can we predict maternal folate status from their folic acid supplementation and their 
dietary folate intake? Do we really need to recommend folic acid periconceptionally or simply  
promote healthy dietary patterns? Could be valuable to measure biomarkers before advice?  
What is the real intake and the recommendations in Portugal? Which are the consequences 
for the new-born and for the mother from high supplementation? 
This study aims to answer to two specific objectives. The objectives, methods, results and 
conclusions for each one are described separately. 
Study 1 
Aim 1: To summarize the recommendations on folate and folic acid intake in the 
periconceptional period provided by official health organizations in different countries 
worldwide.  
Methods 1: Observational descriptive analysis of data collected from official national health 
organizations websites of 36 countries worldwide (25 European, including 22 European Union 
countries; 4 BRICS; 3 Asian Tigers; all The Group of Eight; and Australia) and from the World 
Health Organization website, concerning folate and folic acid recommendations in the 
periconceptional period. 
Results 1: Recommendations differed between countries, although the majority recommended 
400 µg/day of folic acid at least one month before conception until three months of pregnancy. 
In Portugal there are no official recommendations regarding the dose. There is a consensus in 
the recommendation of a healthy diet, naturally rich in folate. The daily recommended folate 
intake for pregnant women could be summarised mainly in three different recommendations: 
500 µg of folate, 550 µg of dietary folate equivalents (DFE) or 600 µg of DFE. For women in 
childbearing age the recommendation ranges from 300 µg/day of DFE to 400 µg/day of DFE 
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or folate. Some countries emphasize the importance of a healthy diet with no need of folic acid 
supplementation. By contrast, others advice high supplementation plus mandatory fortification.  
Conclusion 1: Folic acid recommendations worldwide are predominantly of 400 µg of folic acid 
in the periconceptional period, independently of the national epidemiology of intake and 
disease. Regardless the lack of a quantitative recommendation, in Portugal the only 
commercialized doses of folic acid are of 5 mg, also prescribed to low risk women. High intakes 
of folic acid have being shown through pregnancy outcomes studies, both in mother and child, 
early and later in life, to have adverse effects. Accurate recommendations are needed in 
Portugal. 
 
Study 2  
Aim 2: To estimate the association between folate intake and folic acid supplementation in the 
periconceptional period and folate status in early pregnancy. 
Methods 2: Cross-sectional analysis of data collected from 84 pregnant women, in one public 
hospital in Porto, with dietary assessment by a semi-quantitative food frequency questionnaire 
and food diaries, serum and erythrocyte folate status assessment, socio-demographic and 
lifestyle variables, past medical history, health status during pregnancy, and use of vitamin and 
mineral supplements. 
Results 2: Intake of folate from diet was below the recommended level for pregnancy in 91.7% 
pregnant women. Although, the median folate plus folic acid intake was nearby 6 mg DFE, six-
folder higher than the recommendations for folate intake plus supplementation of folic acid for 
prevention of NTD. The folic acid intake alone was 12-folder higher, without distinction from 
high risk women. Only 4.8% were classified as folate deficiency using serum folate 
assessments, but 13.1% through erythrocyte folate assays. It was identified a modest 
association between folic acid supplementation and maternal folate status. Being a planned 
pregnancy was the main determinant of using folic acid supplements before pregnancy. 
Conclusion 2: The study identified a modest association between folic acid supplementation 
and folate status. It was shown a low intake of folate during pregnancy and a late initiation of 
the supplementation, indicating that guidelines are unlikely to be effective. Only being a 
planned pregnancy was the main determinant of starting folic acid supplementation in the 
preconception, as desirable. 
 
General conclusion 
Recommendations differed between countries, although the majority recommended 400 
µg/day of folic acid at least one month before conception until three months of pregnancy. The 
recommended folate and folic acid vs. the real intake, differs greatly in the Portuguese 
population. The folate intake from diet is below recommendations and the folic acid 
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supplementation is 12-folder above international guidelines, and the supplementation happens 
frequently after the desirable period. High doses are associated with unmetabolized folic acid 
in the body, fact that is more and more associated with adverse effects in current researches. 
In Portugal new guidelines are needed, including quantitative recommendations regarding folic 
acid supplementation and emphasizing a healthy dietary pattern. 
 
Keywords 
Folate, periconceptional folic acid supplementation, neural tube defects, folic acid fortification, 
national recommendations for folic acid supplementation, women of childbearing age, folate 
status, folate intake assessment. 
 
RESUMO 
Introdução 
A suplementação em ácido fólico no período periconcecional está associada à redução do 
risco de malformações do tubo neural. Mas em muitos casos esta suplementação ocorre após 
o período desejado, apresentando esta suplementação algumas limitações em termos de 
eficácia, ao contrário do que acontece com a fortificação dos alimentos em ácido fólico. 
Contudo, após um entusiasmo inicial no que concerne à fortificação em ácido fólico, novas 
preocupações surgiram em relação aos potenciais efeitos adversos decorrentes da 
fortificação massiva de alimentos e a suplementação com elevadas doses de ácido fólico, 
nomeadamente na ocorrência de efeitos adversos na gravidez com reflexos, a curto e a longo 
prazo, na saúde da mãe e do filho. 
Relativamente à alimentação, tem sido demonstrado que quer o padrão alimentar como os 
métodos de confeção condicionam as quantidades de folato ingeridas, sendo o padrão 
alimentar dito saudável mais rico neste nutriente. 
Partindo destes pressupostos, surgem algumas questões, tais como: O que está a ser 
recomendado em termos de ingestão de folato e de suplementação em ácido fólico no período 
periconcecional, em diferentes partes do mundo? Poderemos prever os níveis de folato 
maternos a partir da sua ingestão alimentar e da sua toma de suplementos? Precisaremos 
mesmo de recomendar a toma de suplementos no período periconcecional ou bastará fazer 
um correto aconselhamento alimentar? Será útil medir os níveis sanguíneos de ácido fólico 
antes de fazer o aconselhamento? Qual é a realidade portuguesa em termos de ingestão de 
folato e de suplementação de ácido fólico no período periconcecional e quais as 
recomendações existentes? Quais as consequências de uma elevada suplementação para as 
mães e para os filhos? 
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Este estudo pretendeu responder a dois objetivos específicos. Os objetivos, métodos, 
resultados e conclusões são descritos em seguida, separadamente. 
Estudo 1 
Objetivo 1: Sistematizar as recomendações oficiais relativas à ingestão de folato e de ácido 
fólico no período periconcecional, veiculadas por organizações nacionais de saúde de 
diferentes países do mundo. 
Métodos 1: Análise descritiva dos dados oficiais recolhidos a partir dos websites de 
organizações nacionais de saúde de 36 países de todo o mundo (25 países europeus, 
incluindo os 22 países da União Europeia; 4 países pertencentes ao BRICS; 3 países incluídos 
nos “Tigres Asiáticos”; os 8 países do G8; Austrália) e do website da Organização Mundial de 
Saúde, relativamente às recomendações para a ingestão de folato e de ácido fólico no período 
periconcecional. 
Resultados 1: As recomendações diferem entre países, contudo a maioria recomenda 400 
µg/dia de ácido fólico pelo menos um mês antes da conceção e durante os primeiros três 
meses de gravidez. Em Portugal não existem recomendações relativamente à dose de 
suplemento. Existe o consenso de que uma alimentação saudável é naturalmente rica em 
folato. A dose diária recomendada para a ingestão de folato durante a gravidez, reportada 
pelos diferentes países, pode ser resumida em três recomendações: 500 µg de folato, 550 µg 
de equivalentes de folato (EF) ou 600 µg de EF. Para mulheres em idade fértil as 
recomendações variam de 300 µg/dia de EF a 400 µg/dia de EF ou folato. Alguns países 
enfatizam a importância de uma alimentação saudável sem necessidade de suplementação 
em ácido fólico. Por oposição, outros aconselham elevadas doses de suplementação 
acrescidas de fortificação obrigatória. 
Conclusão 1: As recomendações para ácido fólico em diferentes partes do mundo incidem 
predominantemente nos 400 µg de ácido fólico no período periconcecional, 
independentemente da situação epidemiológica do país em termos de ingestão e padrão de 
doença. Apesar da falta de uma recomendação quantitativa, em Portugal apenas são 
comercializados suplementos de ácido fólico de 5 mg, prescritos inclusivamente em mulheres 
com baixo risco de malformações congénitas. Elevadas ingestões de ácido fólico têm sido 
associadas a efeitos adversos na gravidez com reflexos, a curto e a longo prazo, quer para a 
mãe, quer para o filho, na saúde. São necessárias recomendações mais precisas em Portugal. 
 
Estudo 2  
Objetivo 2: Estimar a associação entre a ingestão de folato e a suplementação em ácido fólico, 
durante o período periconcecional, com os níveis maternos de folato. 
Métodos 2: Análise transversal de dados relativos a 84 mulheres grávidas, num hospital 
público do Porto, incluindo avaliação da ingestão alimentar através de um questionário semi-
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quantitativo de frequência alimentar e de diários alimentares, doseamentos séricos e 
eritrocitários de folato, recolha de dados sociodemográficos e de estilos de vida, história de 
saúde, estado de saúde na gravidez e toma de suplementos vitamínicos e minerais. 
Resultados 2: A ingestão de folato proveniente da alimentação encontrava-se abaixo dos 
níveis recomendados para 91,7% das mulheres. No entanto, a mediana de ingestão do folato 
dietético acrescido do ácido fólico proveniente dos suplementos situava-se perto dos 6 mg de 
EF, seis vezes superior às recomendações para a prevenção das malformações do tubo 
neural. Considerando somente as recomendações para a suplementação em ácido fólico, a 
ingestão era 12 vezes superior, independentemente de se tratar de mulheres de elevado risco 
ou não. Somente 4,8% das mulheres apresentavam níveis baixos de folato sérico, mas 13,1% 
apresentavam níveis deficientes de folato eritrocitário. Observou-se uma fraca associação 
entre ingestão de folato e ácido fólico com os níveis sanguíneos maternos de folato. O facto 
de se tratar de uma gravidez planeada foi o principal determinante da suplementação na 
preconceção. 
Conclusões 2: Foi identificada uma fraca associação entre suplementação em ácido fólico e 
os níveis maternos de folato. Encontrou-se uma baixa ingestão de folato na gravidez e um 
início de suplementação tardio para muitas mulheres, sugerindo que as recomendações 
existentes não estão a ser efetivas. O principal determinante para o início da suplementação 
na preconceção, como desejado, foi o facto de se tratar de uma gravidez planeada. 
 
Conclusões gerais 
As recomendações para ácido fólico em diferentes partes do mundo incidem 
predominantemente nos 400 µg/dia de ácido fólico no mês anterior à conceção, prolongando-
se durante os primeiros 3 meses de gravidez. As recomendações para folato e para ácido 
fólico diferem bastante do que é praticado pelas mulheres portuguesas. A ingestão dietética 
de folato encontra-se abaixo das recomendações e a suplementação é cerca de 12 vezes 
superior às recomendações internacionais, ocorrendo frequentemente após o período no qual 
a suplementação apresenta maior benefício. Elevadas doses de suplemento associam-se a 
elevadas doses de ácido fólico não metabolizado no organismo, que parecem associar-se a 
efeitos adversos, segundo a investigação atual. Em Portugal são necessárias novas 
recomendações, incluindo orientações quantitativas relativamente à suplementação em ácido 
fólico e enfatizar a importância da prática de uma alimentação saudável. 
 
Palavras-chave 
Folato, suplementação periconcecional em ácido fólico, defeitos do tubo neural, fortificação 
em ácido fólico, recomendações para a suplementação em ácido fólico, mulheres em idade 
fértil, níveis séricos de folato, avaliação da ingestão de folato.  
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INTRODUCTION 
1. Folic acid in the periconceptional period: benefits and potential risks 
The findings, in 1991, by the British Medical Research Council(1), and, in 1992, by the 
Hungarian National Institute of Hygiene, a World Health Organization (WHO) Collaborating 
Center for the Community Control of Hereditary Diseases, about the effect of folic acid 
supplementation in the periconceptional period in reducing the risk of Neural Tube Defects 
(NTD)(2), were revolutionary and it maintains consensual nowadays(3).  
In the British study was carried out a randomised double-blind prevention trial at 33 centres in 
seven countries, which results showed that folic acid supplementation of 4 mg, from before 
conception until 12 weeks of pregnancy, reduced the risk of recurrence of NTD by 72%(1). 
Regarding serum folate, at last visit before becoming pregnant (median 7 days) the value was 
substantially higher in the folic acid supplemented groups (varying from 23 to 194 ng/ml from 
percentile 10 to percentile 90) than the unsupplemented groups (varying from 3 to 9 ng/ml, 
respectively). The erythrocyte folate results were similar, so compliance was good(1). In the 
end of the study, besides the recommendations of folic acid supplementation for preventing 
recurrence of NTD, was recommended that public health measures should be taken to ensure 
that the diet of all childbearing women contains an adequate amount of folate(1). 
In the Hungarian study, the folic acid supplementation of 0.8 mg for at least one month before 
conception and until the date of the second missed menstrual period (approximately 8 weeks 
of pregnancy) decreased by 58% the incidence of a first occurrence of neural tube-defects(2). 
Furthermore, folic acid seems to prevent other congenital anomalies (cleft lip(4, 5) and 
cardiovascular malformations), but the results were not completely consistent(2, 6-8). 
In order to prevent NTD, and considering that neural tube closes by day 28(9) (4 weeks after 
conception – conceptional age – corresponding to the 6 weeks of pregnancy – gestational 
age), when most women do not know they are pregnant(8), even in the planned pregnancies, 
folic acid supplementation should occurs in the periconceptional period(3, 10). 
Periconceptional period is commonly defined generically as occurring around the time of 
conception, from before conception to early pregnancy, but some authors establish a more 
specific definition, as a 5-6 months period in women embracing oocyte growth, fertilization, 
conceptus formation and development to week 10 of gestation (coinciding with the closure of 
the secondary palate in the embryo) (Figure 1)(11). 
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Figure 1. The periconceptional period in humans, depicting the five stages of reproductive development 
against their time course in weeks (adapted from Steegers-Theunissen et al. 2013 (11)). 
 
For that reason, supplementation occurs frequently after the desirable period(12, 13). 
Moreover, there is not only one recommendation regarding dosage of folic acid 
supplementation, it is variable from different countries and different entities (Chapter 1). But 
real intake and supplementation commonly do not reflect recommendations (Chapter 2).  
High blood levels of folate were associated with a lower risk of cardiovascular disease and 
cancer, not confirmed by randomised trials(14). And folic acid supplementation has been 
associated with a lower risk of stroke(15, 16). Additionally, folic acid due to its water-soluble 
character was traditionally considered safe(17).This motivated some countries to opt for folic 
acid fortification in cereal products, namely flour. Nowadays, flour fortification with folic acid is 
mandatory in 47 countries, mainly in the continents of America and Oceania, in the Middle East 
and few in Africa(18, 19). 
After mandatory fortification, many questions arise, regarding individual liberty (to choose 
fortify or not fortify foods) and the concern about feasible monitoring of potential hazards of the 
fortification.  
In the Dietary Reference Intakes (DRI), the only adverse effect considered that may result from 
excess intake of folic acid was the onset or progression of neurological complications in people 
with vitamin B12 deficiency(3). However, it was emphasized that the studies that evaluated the 
periconceptional use of supplemental folic acid (in doses of approximately 0.4 to 5.0 mg) to 
prevent NTD, were not specifically designed to assess adverse effects(8), and the recent 
studies are inconclusive, so more studies are considered needed(20). 
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Regarding folic acid in fortified foods (folic acid is added to refined cereals to a level that 
doubles the amount lost during the refining process(21)), no proven adverse effects have been 
associated with until now, although more studies are needed to analyse new data(20). 
However, it has been discussed the possible carcinogenicity of folic acid(8, 22), supported by 
biologically plausible mechanisms - folate is essential in biological methylation reactions and 
nucleotide synthesis and impairment of these processes are thought to be  involved in cancer 
development(14). Some researchers suggested that could exist a link between high folic acid 
intake and cancer incidence(23, 24), but this is not consensual(14, 25, 26).  
It is known that through exposure to mandatory food fortification and vitamin supplement use, 
large populations have an unprecedented high folic acid intake(27). And that the capacity of 
the body to convert folic acid to 5-methyl-THF is limited(28). Unmetabolized folic acid has been 
detected in the systemic circulation following folic acid supplementation and ingestion of 
fortified foods at oral doses above 260 μg(28), exposing body tissues to a form of the vitamin 
not encountered before(29). Another research shown that the absorption and 
biotransformation process of folic acid is saturated at a maximum dose of 400 μg (not at 100 
μg neither 200 μg)(30). 
In other study it was observed that plasma concentrations of unmetabolized folic acid remained 
low even though they were consuming higher doses (5 mg) and that hepatic metabolic capacity 
is highly variable(31). Approximately 40% of older adults in USA have unmetabolized folic 
acid(32). And it was found an inverse relation between the presence of unmetabolized folic 
acid in plasma and natural killer cell cytotoxicity, but further studies on immune function and 
health are needed(27). Given the possibility that excessive folic acid exposure may relate to 
cancer risk, monitoring the long-term effect should be warranted(32-34) especially considering 
that the vast majority of the population are not at risk of NTD(32). 
It can be considered that high doses of folic acid may act as a xenobiotic and not a nutrient(35). 
In one animal study (mice), it was shown that methyl supplements (including folic acid) have 
strong effects on DNA methylation and phenotype and are likely to affect long-term health, so 
optimum, rather than minimal,  maternal dietary supplements for the health and longevity of 
offspring should be intensively investigated(36). 
The biochemical properties of the folate and folic acid modelled pathway of a theoretical study 
suggest that there is an optimum folate concentration above which folate-reaction velocities 
decline(37). This requires confirmation in experimental studies, yet illustrates how an 
interdisciplinary approach can help understand different aspects of this complicated 
pathway(37). 
One recent meta-analysis showed no benefit but a borderline significant increase in incidence 
of overall cancer in the folic acid group compared to controls(38). When analysing site-specific 
cancers, prostate cancer was the only cancer type where an increase in risk was shown for 
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folic acid supplements(38). The study did not show any evidence for augmented cancer risk 
for fertile women who are recommended folic acid periconceptionally in order to reduce risk of 
NTD(38).  The limited time of follow-up of most randomized control trials was a limitation of 
that review because the time frame for cancer development might exceed the follow-up time 
in many randomized control trials(38). The highly selected population in which most of the 
studies were conducted limits the applicability to the general population and women of 
childbearing age taking folic acid periconceptionally(38). 
Many robust studies about this topic have emerged. A recent a meta-analysis of randomized 
clinical trials concluded that folic acid supplementation has no significant effect (independently 
of the dose and the duration of the supplementation) on total cancer incidence, colorectal 
cancer, prostate cancer, lung cancer, breast cancer or haematological malignancy, but 
reduces the risk of melanoma(39). Concerning supplemented women, a study suggested that 
folic acid supplements of 400 μg or more per day, in postmenopausal women, may increase 
the risk of breast cancer(40).  
In 2007 the World Cancer Research Fund consider that the epidemiological data on the 
relationship between folic acid fortification or supplementation and cancer risk were too 
inconsistent or limited(41). Concerning folate, the conclusion was different: foods containing 
folate (but not folic acid supplements) probably protect against pancreatic cancer(41). 
Some authors consider that safe and effective amounts of folic acid fortification need to be 
scientifically determined by using relevant animal, experimental, and clinical models(34). The 
potential cancer-promoting effect of folic acid fortification in the vast majority of the population 
of countries with mandatory fortification, who are not at risk of NTD but have been 
unintentionally exposed to high amounts of folic acid, is a legitimate public health concern and 
needs careful monitoring(34). 
No adverse effects have been reported with the consumption of excess folate from foods(29). 
Recently, a new concern arises regarding the potential adverse effects of universal maternal 
supplementation on adverse pregnancy outcomes (results of conception and ensuing 
pregnancy(42)), early or later in life, both in mother and child.  Studies has been associated 
maternal folic acid supplementation with an increased birthweight(43-46), insulin resistance in 
children(47), and asthma in children(48, 49).  
Regarding birthweight, there is strong evidence of an inverse association between blood folate 
concentrations and risk of low birthweight(43-46). Folic acid supplementation increased 
birthweight in studies in Africa and India, being this is an important issue for developing 
countries(44). In a review, folic acid at high doses (5 mg) was associated with reduced risk of 
low birthweight(43). In a meta-analysis and systematic review of randomized controlled trials 
studying the effect of supplementation (with minimum duration of 12 weeks) during the second 
and third trimesters (the general supplementation on this period is not consensual), was found 
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a significant dose–response relationship between folate plus folic acid intake and birth weight 
(2% increase in birth weight for every two-fold increase in folate plus folic acid intake)(45). In 
another recent review, folic acid supplementation during pregnancy was associated with 
improvements in the mean birthweight(46). 
In what concerns insulin resistance, in a study of pregnant women in India, maternal 
erythrocyte folate status during pregnancy was associated positively with insulin resistance in 
children at 5 years(47). Based on the supposing that folic acid may be involved in the health 
programming on the fetus and that in utero development may have a rule in metabolic 
syndrome (due to nutritional, hormonal and metabolic changes) it was done a study in animals 
(female rats) to investigate if folic acid supplementation in high doses during periconceptional 
period interfere in the health programming of the fetus to develop metabolic syndrome in the 
postnatal life(50). The results showed that the periconceptional folic acid supplementation in 
high doses may produce an impaired metabolic function in the new-born (during post natal life: 
more weight gain; higher glycaemic values; impaired glucose tolerance as referred before; 
higher insulin values;  higher leptin values; lower adiponectin values) and in the mother (more 
weight gain during the pregnancy)(50). According to the author, this finding should be take into 
account to change actual public health and nutrition politics related to folic acid(50). 
Another animal study (with rats) suggested that folate status in pregnancy can influence 
cardiovascular function in the mother during pregnancy and the developmental origins of 
cardiovascular disease (lower risk) in the offspring in the long term(51). It is a good example 
of how a micronutrient supplement (folic acid) can ameliorate the adverse effects of 
macronutrient imbalance (in this study, a low-protein diet) in pregnancy(51). 
Although the folate metabolism of animals differs from that in humans(52), they are 
indispensable for a better understanding of nutrient-gene interactions in normal pregnancies, 
as well as in those affected by metabolic diseases, such as diabetes and obesity, allowing 
nutritional supplementation to become more specifically targeted(53). 
On the topic of childhood asthma, a recent revision concluded that maternal folic acid intake 
(both in early and later pregnancy) was associated with a short-term increased incidence of 
allergy-related respiratory impairment in children(48). In one prospective birth cohort study 
from Australia, maternal folic acid supplementation between 30 and 34 weeks of pregnancy 
(median daily intake: 300.0 µg; range 27.4–5,895.4 µg) was associated with a 26% increase 
in the relative risk of physician-diagnosed asthma at 3.5 years, but not at 5 years, while there 
was no association with folic acid supplementation before 16 weeks of pregnancy (median 
658.3 µg; range 42.9–5,500.0 µg)(49). Similarly to these results related to first trimester, a 
recent meta-analysis did not support the association between periconceptional folic acid 
supplementation and increased risk of asthma in children, but additional research was 
considered needed(54). By contrast, a study taken in the Norwegian Mother and Child Cohort 
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(a large population based pregnancy cohort following more than 100,000 pregnant women and 
their offspring) found that exposure to folate supplements in the first trimester of pregnancy 
may be associated with increased risk of wheeze and lower respiratory tract infections up to 
18 months of age(55). They concluded that early childhood respiratory health may be affected 
by possible epigenetic influences of methyl donors in maternal diet during pregnancy(55). 
Some years later, in the same cohort, through a nested case-control study, was found that 
higher levels of plasma folate measured during the second trimester of pregnancy were 
modestly associated with increased risk of asthma at age 3(56). The authors consider that 
even if this association is confirmed in additional studies, they do not negate the value of folic 
acid supplementation in pregnancy. In the end they emphasize that additional studies might 
delineate levels below which adverse effects are unlikely and help to fine tune public health 
recommendations to maximize benefits(56). 
Others pregnancy outcomes, such as placental abruption, placental weigh or gestational age 
remains inconclusive(43-46). There are some studies describing an inverse association 
between blood folate concentrations during pregnancy and the risks of placental abruption and 
preterm delivering or small-for-gestational-age infants(44). In contrast, one recent review found 
that folic acid supplementation has no impact on pregnancy outcomes such as preterm 
delivery, and stillbirths/neonatal deaths(46). In another review, folic acid supplementation was 
not associated with any difference in mean placental weight or gestational age(43). Similar 
results were found in a recent meta-analysis (the exposure measured was folic acid 
supplementation in second and third trimesters)(45). In a recent study, in the already 
mentioned cohort (Norwegian Mother and Child Cohort), was not found a protective effect of 
dietary folate intake or folic acid supplementation on spontaneous preterm delivery(57).  
Preconceptional folic acid supplementation starting more than eight weeks before conception 
was associated with an increased risk of preterm delivery, but the results require further 
investigation(57).  
In a study about folic acid and deoxyribonucleic acid (DNA) methylation, was concluded that 
periconceptional maternal folic acid use was associated with epigenetic changes in the child 
that may affect in utero programming of growth and development with consequences for health 
and disease throughout life(58). In another study, folic acid use after 12 weeks of gestation 
influences offspring repeat element and imprinted gene methylation, but further studies are 
needed to understand these epigenetic effects(59). 
It seems that the relationship between maternal folic acid supplementation and pregnancy 
outcomes display a U-shaped association, with adverse effects both with low and high 
dosages. 
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In order to supply new recommendations and to define the adequate range of intake, more 
investigation is needed(48) and a crucial issue is the accurate measure of folate plus folic acid 
intake (folate by diet, folic acid by fortified foods and supplements).  
 
2. Folate and folic acid 
2.1 Definition and sources 
Folic acid was coined in 1941 from Latin folium (leaf) plus ic (origin)(60), because of the 
abundance of folate in green leaves. 
Folate, a water-soluble vitamin B complex (B9), is a group of approximately 150 compounds, 
typically in the form of pteroylpolyglutamates(61) (Figure 2), naturally found in a wide range of 
vegetal (e.g., yeast, leafy green vegetables, pulses, whole cereals, fruits, nuts) and animal 
foods (e.g., liver, eggs), as it can be observed in Table 1. Data available simultaneously in the 
Portuguese(62) and the American(63) food composition tables shows, with few exceptions, 
similar folate content. 
Folic acid, a pteroylmonoglutamic acid, is the synthetic form used in vitamin supplements and 
in fortified cereal products(3).  
  
Figure 2. Chemical structures of common folates (adapted from Gregory 2001(64)). 
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Table 1. Folate content in raw foods, by food groups, from two different food composition tables. 
  Portuguese  Food 
Composition Table(62) 
American Food 
Composition Table(63) 
Food group Food item, raw Folate, DFE* (µg/100 g) 
Unspecified Yeast, baker’s, active dry 2500 2340 
Vegetables 
Watercress 200 9 
Asparagus 175 52 
Savoy cabbage 150 80 
Spinach 150 194 
Brussels sprouts 135 61 
Beet 109 109 
Broccoli 90 63 
Cabbage sprouts 90 - 
Leeks 87 64 
Green bean 80 33 
Kale 78 31 
Portuguese cabbage 78 - 
Artichoke 74 68 
Cauliflower 66 57 
Lettuce 55 38 
Mushrooms 44 17 
Celery 16 36 
Pulses 
Cowpeas, dried 630 633 
Butter bean (lima bean), dried 360 395 
Soybean, dried 328 375 
White beans, dried 300 388 
Chickpeas, dried 180 557 
Broad beans (fava beans), dried 145 423 
Lentils, dried 110 479 
Peas, fresh 62 65 
Cereals, cereal products, and 
potatoes 
Wheat, germ - 281 
Chestnut kernels, peeled 61 58 
Oats, rolled 56 32 
Rice, Brown 55 20 
Biscuits whole wheat cereal, Weetabix 50 46 
Potato 35 18 
Spaghetti, dry, unenriched 34 18 
Bread, wheat 29 99 
Corn, dry 26 19 
Rice, white 19 9 
Fruits 
Strawberry 47 24 
Kiwifruit 42 25 
Mango 36 43 
Raspberry 33 21 
Orange 31 34 
Tangerine 21 16 
Banana 14 20 
Nuts 
Peanut kernels 110 240 
Walnut, kernels 66 98 
Pistachio 58 51 
Pine nut, kernels 57 34 
Almond, kernels with skin 49 50 
Milk and dairy products 
 
Cheese, camembert 50 62 
Cheese, flamengo, 45% fat 39 - 
Yogurt, flavoured, semi-skimmed 6 9 
Meat, fish, seafood and eggs 
 
Beef, liver 330 290 
Egg, whole, fresh 50 47 
Meat, Beef 16 5 
Poultry, Chicken 13 9 
Fish, Salmon 10 18 
Fats and oils Olive oil 0 0 
- Blank mean that no information was available. *DFE: Dietary Folate Equivalents (μg) = food folate (μg) + (1.7 × folic acid (μg))(3, 
21).  Note: to build this table it was chosen the folate richest foods of each food group according to the Portuguese Food 
Composition Table(62).  
 
                                                                                                                           
14 
 
2.2 Intake and availability 
Folate, being a group of compounds in the reduced form, is easily oxidized(61) becoming 
inactive, opposed to folic acid, a stable fully oxidised molecule(65). The degree of loss can be 
influenced by several factors, including extreme shifts on pH, heat, light(66), and also oxygen 
content, metal ion concentrations, antioxidant levels, duration and product:water ratio(65). 
Folate losses are also highly dependent both on the food (e.g., more losses in vegetal than 
animal origin food (Table 2), more in bigger surface area vegetables(67), and method of 
cooking (e.g., soaking(68); more on boiling vegetables than steaming – although folate loss 
from boiling vegetables is mainly as a result of leaching, and not as a result of degradation, 
being folate preserved on the cooking water(65, 69)). Losses of 50% to 90% may occur during 
storage, cooking, or processing at high temperatures(61). Moreover, the amount of folate 
available in processed and stored foods can be significantly lower than in raw products. In a 
recent study was observed that pre-treatment and freezing technology significantly decreased 
folate content only in vegetables with the largest degree of fragmentation and the smallest 
size, and that folate content decreased with the time of frozen storage(70). For example, in 
frozen cauliflower, the folate loss exceeded 95% compared to the fresh product just after the 
third month of frozen storage, and in green and yellow beans, significant folate losses (at the 
level of 75% and 95%, respectively) were observed no earlier than after nine months of frozen 
storage(70).  
For this reason it is recommended that public health efforts should incorporate practical advice 
on storage and cooking to increase folate intake, helping to optimise folate status(65).  
 
Table 2. Folate content of a healthy nutrition plan (prudent dietary pattern) compared to an unhealthy 
plan (Western dietary pattern), with 2000 kcal, built with raw vs. cooked foods  
  Prudent dietary pattern* 
 (2000 kcal) 
Western dietary pattern** 
 (2000 kcal) 
Food group One 
food 
portion 
Raw 
food 
Folate, 
DFE 
(µg/***per 
portion) 
Raw food  
Nutrient 
Retention 
Factor****
Cooked 
food  
Number 
of food 
portions 
per day 
Folate, 
DFE 
(µg/day) 
Raw 
food 
Folate, 
DFE 
(µg/day) 
Cooked 
food 
Number 
of food 
portions 
per day 
Folate, 
DFE 
(µg/day), 
Raw 
food 
Folate, 
DFE 
(µg/day), 
Cooked 
food 
Vegetables 180 g 79 (n=30) 70 4.0 316 221 2.0 158 111 
Pulses 25 g 
dried 
70 (n=11) 45 1.5 105 47 0.2 14 6 
Cereals, cereal 
products, potatoes 
35 g 
dried 
11 (n=28) 75 7.0 77 58 5.8 64 48 
Fruits 160 g 16 (n=30) 50 4.0 64 32 2.0 32 16 
Nuts 15 g 10   (n=6) 80 - - - - - - 
Milk and dairy 
products 
250 ml 
of milk 
10 (n=39) 80 2.0 20 16 2.0 20 16 
Meat, fish, seafood, 
and eggs 
30 g 3 (n=57) 80 2.8 8 6 7.0 24 19 
Fats and oils 10 ml 
of oil 
0 (n=15) - 1.8 0 0 4.8 0 0 
Total    65*****  590 381  312 216 
Total reheated   95   362   205 
Total with raw fruit      413   232 
Comparison      ≈ 50% less of folate in the unhealthy plan 
DFE: Dietary Folate Equivalents. 
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*According to the Food Guide for the Portuguese Population(71). The value of 2000 kcal was obtained through the estimated 
calorie needs for groups(21), based on the Estimated Energy Requirements, considering the female group in the childbearing age 
(from 14 to 50 years(3)), moderate physical active. The food portions were used according to the Food Guide for the Portuguese 
Population(71). The folate content of the portions was calculated based on the Portuguese Food Composition Table(62).  
**Characterized by higher consumption of the food groups Meat and Fats and lower of Fruits and Vegetables(72, 73). The number 
of food portions were obtained considering the proportions of the Portuguese Food Balance(73).  
***Median folate content per portion (n = number of varieties(62) included per food group).   
****Median Nutrient Retention Factor. True retention is defined as the measure of the proportion of the nutrient remaining in the 
cooked food in relation to the nutrient originally present in the raw food(74, 75). The resulting values account for the nutrient 
content retained in a food after losses due to heating or other food preparation steps (e.g., baked, boiled with water drained, boiled 
with water used, broiled, dried in some fruit, fried, poached, simmered, steamed, roasted)(75).  
*****The global Nutrient Retention Factor for folate in the healthy nutrition plane was calculated (total folate cooked ÷ tot al folate 
raw x 100). 
 
Apart from cooking losses, the folate intake also depends on the dietary pattern. Through the 
analysis of the Table 2, it is possible to conclude that the folate content of the healthy nutrition 
plan (prudent dietary pattern) is clearly superior to the unhealthy plan (Western dietary pattern), 
with a value of 413 µg of Dietary Folate Equivalents (DFE) (considering cooked food, except 
fruit), that is similar to the Recommended Dietary Allowances (RDA)(3) for women in the 
childbearing age. Therefore, a prudent dietary pattern gives the appropriate amount of folate, 
as it is expected for every nutrient. The value could be even higher if the richest folate foods 
of each food group were included in a higher proportion and if the methods of preparing and 
cooking were only the best to minimize cooking losses (e.g., cutting the vegetables in big 
pieces, steaming, boiling for few time and using the water). 
These results seem to be consistent with other research which showed that dietary patterns 
have clearly a significant rule in folate intake(72). A prudent dietary pattern (Table 2) 
(compared to a Western dietary pattern and other patterns), even in the era of fortification, may 
decrease the risk of NTD and some heart defects in folic acid nonusers(72), representing in 
United States of America (USA) 60% of women of childbearing age(76). It was concluded that 
in preconceptional counselling should be emphasized the need to make healthy dietary 
choices to optimize not only pregnancy outcomes but also maternal health(72). 
A different way of rising folate status is trough concentrate capsules of fruit and vegetables, a 
more natural source compared to folic acid supplements, and without shown side effects. In a 
double-blind placebo controlled study, the results showed that the supplementation with a 
concentrate of fruit and vegetable juice in capsules (provided approximately 420 μg folate), in 
the absence of dietary modification, increased serum folate by 174.3% (from 8.16 to 22.4 
ng/ml, in average), that was correlated with a decrease in plasma homocysteine of 19.9%(77). 
 
Another important issue is the folate bioavailability. It is accepted that it could range greatly 
between 25 to 50%(3), depending on the chemical structure(3, 64, 78), the presence of 
inhibitors and binders(61), and the person’s nutritional status (e.g., deficiencies of iron and 
vitamin C can impair folate use)(61).  In some vegetables and citrus fruits it can reach 60% to 
98% of bioavailability(79). An additional factor is the diet composition, but this is a theoretical 
problem, since we cannot quantify this effect(8, 64). 
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Regarding folic acid (the already mentioned synthetic form) it appears to be highly bioavailable, 
but is affected by the circumstances of the intake: nearly 100% taken on an empty stomach, 
and about 85% when added to foods(3, 78).  
Trying to adjust the referred differences of bioavailability, the Institute of Medicine defined the 
concept of DFE that places all sources of folate and folic acid on a comparable basis [DFE 
(μg) = folate (μg) + 1.7 × folic acid (μg)], to establish the RDA(3). The factor 1.7 is the ratio 
between the bioavailability of folic acid consumed with food (85%) and the bioavailability of 
folate (assumed to be 50%). This factor may change in the future, when more accurate 
estimates arise(64). 
 
2.3 Absorption, Transport, Storage, Metabolism and Excretion  
After intake, folate is firstly hydrolysed to monoglutamate forms in the gut and then absorption 
occurs by active transport mainly in the jejunum(61). When folic acid is used, since it is already 
in a monoglutamate form, it also can be absorbed by passive diffusion(3, 8). In the intestinal 
mucosal cell folate is reduced to tetrahydrofolate (THF), the active form of folate(61). Folate is 
taken up from the portal circulation by the liver, where it is metabolized and retained or released 
into the blood or bile(3). About half of total body folate is stored in the liver, as polyglutamates 
of 5-methyl-THF and 10-formyl-THF(61). Approximately two-thirds of folate in plasma is bound 
to protein. A part of the folate is excreted in the urine, bile, and faeces(80). Some reports 
indicate that daily folate excretion on a normal diet ranges from 5 to 40 µg/day(8, 81). A study 
of eight healthy pregnant women, not on supplementary folic acid, found a substantial increase 
in folate excretion from a non-pregnant mean of 3.5 µg/day to a mean of 14.0 µg/day during 
pregnancy(82).  
THF (with its bound components) acts as a co-enzyme in many synthesis reactions in the 
metabolism of amino acids and nucleotides by donating or accepting single carbon units (e.g., 
formation and maturation of red and white blood cells; de novo synthesis and repair of DNA; 
synthesis of methionine from homocysteine (Figure 3) – this conversion also requires vitamin 
B12, which deprivation can lead to a functional secondary folate deficiency – both having 
essential role in gene stability)(8, 61). 
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Figure 3. Folate and folic acid metabolism (adapted from Ulrich et al. 2006(37)). 
THF: tetrahydrofolate; DHF: dihydrofolate; RFC: reduced folate carrier; hFR: human folate receptor; MTHFR: 5,10-
methylenetetrahydrofolate reductase; DHFR: dihydrofolate reductase; GART: glycinamide ribonucleotide transformylase; 
AICARFT: 5-amino-imidazole-4-carboxamide ribonucleotide transformylase; AICAR: 5-aminoimidazole-4-carboxamide 
ribonucleotide; GAR: glycinamide ribonucleotide; SAM: S-adenosylmethionine; SAH: S-adenosylhomocysteine, SHMT: serine-
hydroxy-methyltransferase; MS: methionine synthase; TS: thymidylate synthase; MT: methyltransferases. 
 
There is evidence that folate may interact with several substances – alcohol (in a chronic 
intake), tobacco, drugs (e.g., nonsteroidal anti-inflammatory, in very large therapeutic doses; 
anticonvulsant, in chronic use; anti-cancer and anti-autoimmune diseases methotrexate, in 
chronic therapy; antibiotic trimethoprim; diuretic triamterene;  antimalarial pyrimethamine; anti-
inflammatory bowel diseases sulfasalazine) – by different mechanisms (e.g., substance 
associated with low intake, impair intestinal absorption and hepatobiliary metabolism, increase 
renal excretion, antifolate activity), increasing folate requirements(3). Oral contraceptives 
containing high levels of oestrogens were suggested to have adverse effects on folate status,  
but its use has not been reported to influence folate status in large-scale population surveys 
or in metabolic studies in which dietary intake was controlled(8). 
About dietary interactions related to dietary fibre, a suggestive evidence of a positive 
association between dietary fibre intake and folate status in humans was reported, and in 
animals, evidence indicated that synthesis of folate by intestinal bacteria influences folate 
status(8). 
Folate and its derivatives are involved in numerous biochemical reactions that are catalysed 
by many different enzymes, consequently, folate metabolism is under genetic control, and as 
expected, genetic heterogeneity(8, 20), but not yet well understood(44). Polymorphism in the 
5,10-methylenetetrahydrofolate reductase (MTHFR) may be involved in this heterogeneity, as 
well as in the methylenetetrahydrofolate dehydrogenase (MTHFD1)(20). Also polymorphisms 
in the reduced folate carrier gene seems to be a NTD risk factor, in one studied on Chinese 
population(83). 
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Folate requirements are increased in specific physiological (pregnancy and lactation) and 
pathological conditions. During pregnancy occurs a marked acceleration in single-carbon 
transfer reactions, due to uterine enlargement, placental development, expansion of maternal 
erythrocyte number, and foetal growth(8, 9, 84).Additionally, folate is excreted by urine to a 
greater extent(85). Higher folate requirements are also well documented in chronic use of 
some therapeutic drugs, burns, hepatitis, infection, inflammatory diseases, cancer, surgery, 
dialysis, haemolytic anaemia, and malabsorption states (e.g., celiac disease, Crohn's 
disease)(86). 
In summary, factors considered when estimating the folate requirement include the 
bioavailability of folic acid and folate, nutrient interactions (coexisting Iron or vitamin B12 
deficiency may interfere with the diagnosis of folate deficiency), interactions with other food 
components, smoking, folate-drug interactions, and genetic variations(8). 
 
 
2.4 Folate status assessment 
The more consensual biomarker for folate status is its assessment in the erythrocytes, 
sometimes in conjunction with plasma homocysteine concentrations(61).  
Erythrocyte folate concentration is an indicator of long-term status, because uptake of folate 
occurs mainly during erythropoiesis and the erythrocyte lifespan is about 120 days(8). Another 
possibility is the determination of the serum (or plasma) folate concentration, however it is a 
short-term status indicator of dietary folate intake (decreases in intake may be reflected in 
serum levels within 1 to 3 weeks(8). For that reason, in population surveys it is generally 
assumed that measuring alone serum levels does not differentiate between what may be a 
transitory reduction in folate intake or a chronic folate deficiency accompanied by depleted 
folate stores and functional changes(8). It may be a useful diagnostic test if interpreted 
correctly in conjunction with other folate status indices(8). 
Another possibility could be urinary folate, however this biomarker is not a responsive indicator 
of folate status, because excretion continued even in the face of advanced folate depletion(8). 
Regarding the cut off points, an erythrocyte folate < 305 nmol/l (140 ng/ml) and a serum folate 
< 7 nmol/l (3 ng/ml) indicates a negative folate balance(8). The concentrations suggested by 
WHO for defining folate deficiency, based on metabolic indicators, are slightly different: < 340 
nmol/l (151 ng/ml) for erythrocyte folate and < 10 nmol/l (4 ng/ml) for serum folate(44). The 
conversion factor used to transform the units (nmol into ng) was 2.265(44). 
Moreover, for assessing folate status in population in all age groups, using macrocytic anaemia 
as a haematological indicator, WHO establish the following value for erythrocyte/red blood cell 
folate: deficiency < 226.5 nmol/l (< 100 ng/ml). And values for serum/plasma folate: deficiency 
< 6.8 nmol/l (3 ng/ml); possible deficiency 6.8-13.4 nmol/l (3-5.9 ng/ml); normal range 13.5-
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45.3 nmol/l (6-20 ng/ml); elevated (based on the assay’s upper limit capabilities without 
dilutions, and not on biological implications for health) > 45.3 nmol/l (>  20 ng/ml)(87).  
An average decline in serum folate of 10 nmol/l (from 20 to 10 nmol/l) during the 40 weeks of 
gestation, may represent a physiologic response to pregnancy, but the mechanism is 
unknown(88). The pattern of changes in erythrocyte folate varies, with a decline observed in 
early pregnancy followed by a slight increase in mid-pregnancy. The most plausible causes for 
the declines in blood folate include increased folate demand for the growth of the fetus and 
utero-placental organs and low folate intake(88). 
 
Another important topic is the analytical method. Universal highly accurate method does not 
exist, being more difficult to establish universal cut-off points(8), but it has been developed(20). 
Erythrocyte is the more time-consuming and costly test because before analysis requires 
sample pre-treatment – and this introduces additional variation into results from different 
laboratories(89). Others analytical issues that influence results are reductions in the oxygen 
saturation of haemoglobin and decreased haematocrit, both increase the results(89). The other 
biomarker, serum folate, more frequently showed the higher correlation with homocysteine, a 
sensitive marker of deficiency(89).  Similarly, both plasma and erythrocyte folate were shown 
to increase in response to folic acid supplementation and fortification(89).  However, plasma 
folate generally gave the greater response at both short- and long-term follow-up and was able 
to distinguish different supplementation doses(89).  
Studies have shown that very few patients would have their clinical outcome altered by the 
measurement of erythrocyte folate in addition to serum folate(89).  However, serum folate is 
the main marker in patients with vitamin B12 deficiency(89). In contrast, after haemodialysis 
sessions erythrocyte folate gives the better assessment of folate status(89). 
Both markers could assess risk of a current pregnancy being affected by a NTD(89). However, 
between pregnancies erythrocyte folate appears to be the better risk indicator(89). Studies 
looking for an association of erythrocyte folate with NTD risk based on estimating erythrocyte 
folate levels in blood samples taken early in pregnancy are preferred because maternal folate 
status is likely to change during pregnancy and postpartum(8). MTHFR polymorphisms may 
alter folate concentrations in populations with low folate status Both serum and erythrocyte 
folate are able to identify these changes(89). Overall then, as a routine test of folate status, 
serum folate appeared to offer the best combination of test cost and clinical information, 
because it is cheaper and faster to perform than erythrocyte folate, is influenced by fewer 
analytical variables and provides an assessment of folate status that may be better than 
erythrocyte folate(89).   
In an original study, folate status of Japanese women of childbearing age was marginally 
deficient, with inadequate concentrations of serum folate (the mean concentrations were 
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5.4±2.1 ng/ml; it was low in 12.1% of the subjects (< 3.0 ng/ml) and was marginal in 58.6% 
(3.0-5.9 ng/ml)), largely due to insufficient folate intake (the mean folate intake was 262±111 
μg/day)(90). The level at which folate deficiency (serum folate, < 3.0 ng/ml) disappeared, 
corresponded to a daily intake of folate exceeding 349 μg/day(90). 
In a study done with Belgium pregnant women, the median erythrocyte folate concentration 
was 436 ng/ml among first trimester and 496 ng/ml among third trimester(12). Few had an 
erythrocyte folate concentration below 140 ng/ml, indicating depletion of folate stores(12).  In 
the first trimester, 39% of women had an erythrocyte folate concentration below 400 ng/ml, 
whereas 15% of the first trimester women had an erythrocyte folate concentration below 300 
ng/ml(12). Among women in the first trimester, 69.1% reported taking folic acid supplements 
of which 41.2% started taking them before pregnancy(12).  For third trimester, these 
percentages were 76.2 % and 21.9%, respectively(12).  In both trimesters, folate status 
increased significantly with education level and was significantly higher among women who 
planned the pregnancy and who did not smoke(12). Another study shows that the conjunction 
of folate with folic acid intake significantly increased the folate concentration levels in serum 
and in erythrocytes by 47% and 23%, respectively, and lowered the levels of plasma 
homocysteine by 7%(91). This dose-response result may in future be applied for deriving the 
intake dose necessary to achieve the optimal level of a folate biomarker for women of 
childbearing age, as well as for pregnant and lactating women(91). 
 
Aims of the study 
These study aimed: 
1. To summarize the recommendations on folate and folic acid in the periconceptional period 
provided by official health organizations in different countries worldwide (Chapter 1); 
2. To estimate the association between folate intake and folic acid supplementation in the 
periconceptional period and serum folate and erythrocyte folate levels in early pregnancy 
(Chapter 2). 
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CHAPTER 1 – FOLATE INTAKE AND FOLIC ACID SUPPLEMENTATION IN THE 
PERICONCEPTIONAL PERIOD:  RECOMMENDATIONS FROM OFFICIAL HEALTH 
ORGANIZATIONS IN 36 COUNTRIES WORLDWIDE 
 
INTRODUCTION 
Folate intake worldwide 
The population reference intake set by the Scientific Committee on Food of the European 
Union (EU) is 200 μg/day for adults, and 400 μg/day in pregnancy(92). In European countries 
the average folate intake in adults was found to be remarkably similar, around 300 μg/day in 
men, and 250 μg in women(93). 
This values are satisfactory regarding adult population, but clearly insufficient for pregnant 
women and women intended to get pregnant(29). For the last ones an intake higher than 400 
μg/day is considered desirable, namely to protect against NTD(29).  More than 90% of women 
in the childbearing age range dietary folate intakes below this optimal level(29). 
More recent assessments, detailed in the European Health Report of 2009, showed that the 
mean intake of folate, expressed in DFE, was between 203 and 494 μg/day in men and 
between 131 and 392 μg/day in women(94), therefore the reference value by the German 
language countries (D-A-CH: an acronym used to represent the dominant states of the German 
language Sprachraum, related to reference values for nutrient intake by German Society of 
Nutrition, the Austrian Society of Nutrition, the Swiss Society of Nutrition Research and the 
Swiss Association of Nutrition, which are applied also in Hungary, Slovenia and the Czech 
Republic) of 400 μg/day DFE(95) was not met by any country(94),  Nordic countries also 
established specific own recommendations (NNR: Nordic Nutrition Recommendations, by 
Denmark, Finland, Iceland, Norway, and Sweden(96)): 300 μg/day folate for women in general, 
and 400 μg/day folate for women 18-30 years and for women in childbearing age. Comparing 
to the average intake, a similar result was obtained for women in childbearing age: the 
recommendations were not met by any country(94). 
The Portuguese mean daily intake for women was 304±144 μg/day(94). Some researchers 
explained this high intake with the relative high fruits and vegetables quantities available for 
Portuguese population, of 313 kg/year and per capita, contrasting with only 105 kg/year and 
per capita in Bulgaria, for instance(97). 
When comparing countries, it is very important to consider meticulously the methodology. 
Different methods were applied across Europe to estimate the adequacy of micronutrient 
intake, which led to different prevalence estimates of micronutrient inadequacy(98). 
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Criteria to determine Dietary Reference Intakes in pregnancy for folate 
The RDA for folate was based on the amount of folate (in DFE) needed to maintain erythrocyte 
folate, having been also in account data on plasma homocysteine and plasma folate 
concentrations(3). 
During pregnancy the RDA is 600 μg DFE, which, according to the DFE equivalences1, 
corresponds to 600 μg food folate = 360 μg folic acid from fortified food or as a supplement 
consumed with food = 300 μg folic acid from a supplement taken on an empty stomach(3). 
Data from the controlled metabolic study support a RDA of 600 μg/day of DFE based on 
maintenance of normal erythrocyte folate concentrations and agree with the findings from the 
series of population studies that 600 μg/day of DFE is adequate to maintain normal folate 
status in groups of pregnant women(3). 
Risk reduction for NTD was not considered as a basis for establishing the RDA for pregnant 
women(3, 8) A separate recommendation was presented and discussed by the Institute of 
Medicine, USA, as all women capable of becoming pregnant should consume 400 μg/day of 
folic acid from supplements, fortified foods, or both in addition to consuming folate from a varied 
diet(3, 8).  
The Tolerable Upper Intake Level (UL) was established only for folic acid (from fortified foods, 
supplements, or both), being 800 μg for 14 to 18 years and 1,000 μg above 18 years, by the 
Institute of Medicine(3, 8). This values derived from the Lowest-Observed-Adverse-Effect 
Level based on the precipitation or exacerbation of neuropathy in patients with vitamin B12 
deficiency – considering that excessive intake of folic acid may mask the diagnosis(3). In 
childbearing age women, the consumption of folic acid at or above the UL is improbable to 
produce the adverse effects here considered, as the prevalence of vitamin B12 deficiency is 
generally very low (3, 8). Although, adverse effects are possible in women at risk of vitamin B12 
deficiency, like vegans, older adults with atrophic gastritis, those with pernicious anaemia and 
bacterial overgrowth of the gut(3). 
In Europe, the Scientific Committee on Food set a similar UL: 1 mg/day for adults(29). 
 
Inadequate folate intake and congenital anomalies 
Inadequate folate or folic acid intake leads to: a decrease in plasma folate concentration, a 
decrease in erythrocyte folate concentration, a rise in homocysteine concentration, 
megaloblastic changes in the bone narrow and other tissues with high cellular turnover(3) (e.g., 
erythrocytes, leukocytes and epithelial cells of the stomach, intestine, vagina, and uterine 
                                                   
1 1 μg DFE = 1 μg folate = 0.6 μg folic acid from fortified food or as a supplement consumed with food = 0.5 μg folic acid supplement 
taken on an empty stomach. 1 μg folate = 1 μg DFE; 1 μg folic acid from fortified food or as a supplement consumed with food = 
1.7 μg DFE; 1 μg folic acid supplement taken on an empty stomach = 2 μg. 
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cervix(61)) – because lack of folate impair biosynthesis of DNA and consequently reduces cell 
division. This makes it particularly important in embryogenesis(61). 
Those changes ultimately lead to macrocytic anaemia, at first evidenced by a low erythrocyte 
count and eventually by a low haematocrit and haemoglobin, as well(3). 
During pregnancy, some studies support that NTD are associated with altered status of vitamin 
B12, folate, or both(8). Furthermore, folate seems related with other types of congenital 
anomalies, specifically orofacial clefts and cardiovascular malformations, but the results were 
not yet consistent(6, 8). A study in Norway concluded that folic acid supplements use during 
early pregnancy reduced the risk of isolated cleft lip by about a third(4). On the other hand, in 
Canada, the prevalence of orofacial clefts did not change after food fortification with folic acid 
(1.15 per 1,000 before and 1.21 per 1,000 after)(99). 
More recent studies emphasized the role of diet as a whole in the congenital anomalies 
occurrence. In one investigation, was concluded that the use of the maternal Western diet 
increases the risk of offspring with a cleft lip or cleft palate approximately two fold(100). In other 
study, it was observed that high intakes of vegetable protein, fibre, ascorbic acid, iron, and 
magnesium decreased orofacial cleft risk. Authors concluded that a high preconceptional 
intake of nutrients predominantly present in fruits and vegetables reduces the risk of offspring 
affected by orofacial cleft(101). 
Congenital abnormalities represent the first cause of infant mortalities, with an increasing 
proportion (more than 25%) in both developed and developing countries. In the world, more 
than 10% of infant mortalities secondary to congenital abnormalities are caused by nervous 
system abnormalities(102). 
NTD are the most common (from less than 1 to approximately 9 per 1,000 total births) major 
congenital malformations of the central nervous system, constituting an important public health 
problem in terms of mortality, morbidity, social cost, and human suffering(8). 
Another studies, stated that the incidence NTD ranges from 0.5 to 14 per 1,000 live births (52). 
The prevalence in Portugal of NTD was of 9.35 per 10,000 live births in 1997-1999(80).  
They are heterogeneous malformations – anencephaly, meningomyelocele (spina bifida 
aperta), meningocele, and craniorachischisis(8). Techniques have been established for 
prenatal screening of NTD, through assessments in maternal plasma and amniotic fluid. 
The prevalence of NTD has declined considerably during the past three decades due to 
advances in the refined resolution of ultrasonography for in utero foetal examination, the 
clinical availability of serum alpha-fetoprotein measurements, termination of affected 
pregnancies, and folic acid supplements being widely consumed by women in the reproductive 
age group(103). 
The incidence of myelomeningocele in Seattle, USA, was 0.5 per 1,000 births in 1981–1982, 
which then declined to 0.05 in 2001(104). The prevalence of NTD in England and Wales was 
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3.80 per 1,000 live births in 1965, which steadily declined to 0.14 in 1997, that is, a large 
reduction of 96%(105). Conversely, the estimated number of terminations increased 
considerably from 0.04 per 1,000 live births in 1970 to 1.50 per 1,000 live births in 1997(105). 
Contrary to the declining tendency in occidental countries, in Japan was reported that the 
prevalence of spina bifida has barely altered in the past two decades; that is, the prevalence 
of spina bifida per 10,000 live births and stillbirths was 4.3 in 1985, 4.3 in 1995, and 4.7 in 
2005(106). The following factors are likely related to the unaltered prevalence of NTD in Japan: 
first, failure to impart adequate information regarding the important role of folic acid in 
preventing NTD; second, reluctance and/or misunderstanding of the Japanese public toward 
taking supplements during pregnancy; and third, neglect of the traditional Japanese diet that 
is rich in vegetables, fish, and rice, combined with an increasing willingness toward consuming 
fast food(106). 
Among the G8 (The Group of 8: Canada, France, Germany, Italy, Japan, Russia, United 
Kingdom, and USA), the latest prevalence rate between 2000 and 2004 of spina bifida was 
approximately 3 to 4 per 10,000 live births, and stillbirths with or without termination of 
pregnancy, where Germany and Japan exceed this value at 7.41 and 5.32, respectively. It is 
possible that the actual prevalence rate of the latter may be higher because the number of 
pregnancies terminated due to spina bifida was not included in the report(103). 
 
Neurulation is the first organogenetic process to be initiated and completed. It begins in the 
human at approximately 21 days post fertilization and is complete by 28 days. Thus, 
neurulation is ongoing at the time that a woman may first recognize her pregnancy by a missed 
menstrual period(8). 
Evidence from epidemiological studies indicates that heredity is a major contributor (about 
60%)(8). Mutations in the gene for MTHFR would account for approximately 15% of NTD 
cases(8). Indeed, the recurrence risk in a sibling birth is 3% to 5%(8). About 95% of the women 
who deliver infants with NTD have not previously delivered infants with these defects(2). For 
the most cases the inheritance is believed to be polygenic(8). Another cause of NTD (for less 
than 0.1%) are teratogenic drugs, including folate antagonists (specifically aminopterin, 
previously used as an antitumor agent), carbamazepine and valproate (commonly used 
antiepileptic drugs); and retinoids(8). Nutrients have been investigated to have a role in the 
prevention of NTD(8). 
The possibility that folate might be involved in NTD was first raised by Hibbard in 1964(8). Data 
indicate a statistically significant decreasing risk of NTD with increasing dietary folate in 
unsupplemented women, being the median dietary folate in the control group approximately 
300 μg/day(8). A reduced risk of NTD (about 35% to 70%) has been observed for women who 
took a folic acid supplement of 360 to 800 μg/day (being 400 μg the most usual dose) in 
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addition to a dietary folate intake of 200 to 300 μg/day(8). The optimal timing for 
supplementation seems to be during the 4 weeks before and after conception(8). After the first 
month of pregnancy folic acid will not prevent NTD, however, it will contribute to other aspects 
of maternal and foetal health(9). Supplemental folic acid in a dose of 4.0 mg/day promote a 
71% decreased in NTD incidence(8). Although, because NTD represent a heterogeneous 
group of congenital malformations, there are cases not preventable even by large doses of 
folate(8). The mechanism by which folate could reduce NTD risk remains unknown(8). 
An erythrocyte folate concentration greater than 870 nmol/l (400 ng/ml) is associated with a 
significant reduction in NTD risk. Erythrocyte folate concentrations improved significantly only 
in the groups taking folic acid supplements or food fortified; there was no increase in the group 
provided extra food folate or dietary advice(8). It is certainly conceivable that, if taken in 
adequate quantity, food folate will be shown to be as effective as folic acid, but it remains to 
be demonstrated(8). 
 
The recommendation of folic acid for women able of becoming pregnant (400 μg folic acid daily 
from supplements, fortified foods, or both in addition to consuming folate from a varied diet) is 
for intake that exceeds the RDA for folate(8).Explaining, 400 μg folic acid as DFE is  
400 × (1 ÷ 0.6) = 670 > 600 μg (RDA for pregnant). And adding the folate from the diet the 
value become even higher. 
Many population-based studies confirmed that approximately 300 μg folic acid/day consumed 
in conjunction with a low-folate diet prevented folate deficiency in pregnant women(107). 
Reduced risk of NTD (about 35% to 70%) has been observed for women who took a folic acid 
supplement of 360 to 800 μg/day (being 400 μg the most usual dose) in addition to a dietary 
folate intake of 200 to 300 μg/day(8). 
Folate intake is positively associated with erythrocyte folate concentration, and NTD risk is 
inversely associated with both folate intake and erythrocyte folate concentration(8). 
Uncertainties still exist about the relationships among folate intake, erythrocyte folate, and NTD 
risk and about the extent to which the effect of food folate should be distinguished from the 
effect of folic acid from supplements or fortified foods (in some countries fortification is 
mandatory(19), in others is voluntary or neither exist), but the evidence is judged sufficient to 
support a specific recommendation to reduce risk of NTD(8). 
Many countries in the EU recommend women who might become pregnant take folic acid 
supplements in order to reduce risk of NTD occurrence, but public health campaigns promoting 
this advice have been unsuccessful(14, 108). 
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Folic acid fortification and NTD 
One of the possibilities to increase folic acid intake is through food fortification. This possibility 
is special interesting, considering that about 41% of worldwide pregnancies are not 
planned(109), so voluntary supplementation in that cases is virtual impossible. This proportion 
is even higher in developing regions (58% to 64%), and was also high in North America (48%), 
exceeding the proportions in Europe's northern, southern and western regions (39% to 
42%)(109). 
Voluntary fortification is permitted in most European countries, but any has mandatory 
fortification(14). Recently the EU introduced new rules to regulate voluntary food fortification – 
Regulation (EC) 1925/2006(14). 
Countries like USA and Australia implemented mandatory folic acid fortification, respectively 
in years 1998(8) and 2009(33).  
In Australia, in the year after mandatory fortification there was a 77% reduction in the 
prevalence of low plasma folate levels in all samples tested and an 85% reduction in the 
prevalence of low erythrocyte folate levels, showing a significantly reduction in the prevalence 
of folate deficiency(110). The effectiveness of mandatory folic acid fortification programmes in 
the USA and Canada have resulted in significant declines in the occurrence of some NTD by 
28%(111) to 46%(112), respectively. 
However, this enthusiastic results were haunted with the possibility of link between foetal folate 
exposure and cognitive decline, cancer or vascular disease occurrence later in life, due to 
changes in offspring phenotype via epimutations(113). 
Moreover, in a recent review, authors defended that women of childbearing age may not yet 
be adequately targeted, while the general population may be over fortified with folic acid(114). 
It remains uncertain the minimum effective folate intake and status required for NTD 
prevention, and the safe upper folate level(114). Besides folate, several other lifestyle and 
environmental factors as well as genetic variations may influence NTD development, possibly 
by affecting one-carbon metabolism and thus epigenetic events(114). Although mandatory folic 
acid fortification plays a significant part in the reduction of NTD prevalence, but possibly at a 
cost and with a portion of NTD remaining, more effective preventive strategies require better 
understanding of the aetiology of this group of birth defects(114). 
The same point of view is defended by other authors. Countries with mandatory fortification 
achieved a significant increase in folate intake and a significant decline in the prevalence of 
NTD, being this was also true for supplementation trials(115). However, the prevalence of NTD 
at birth declined to approximately 5 cases at birth per 10,000 births and 7-8 cases at birth or 
abortion per 10,000 births(115).  This decline was independent of the amount of folic acid 
administered and apparently reveals a ‘floor effect’ for folic acid-preventable NTD(115). This 
clearly shows that not all cases of NTD are preventable by increasing the folate 
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intake(115).The relative decline depends on the initial NTD rate(115). Countries with NTD 
prevalence close to the observed floor may have much smaller reductions in NTD rates with 
folic acid fortification(115). Additionally, potential adverse effects of fortification on other 
vulnerable population groups have to be seriously considered(115). Policy decisions 
concerning national mandatory fortification programmes must take into account realistically 
projected benefits as well as the evidence of risks to all vulnerable groups(115). 
 
Folic acid supplementation and incidence of NTD 
Periconceptional folic acid supplementation lowers the incidence of NTD significantly, by 20% 
to 60%(52). A Cochrane review that included 4 studies with a total of 6425 women showed 
that periconceptional folic acid supplementation substantially reduces the incidence of NTD 
(relative risk 0.28, 95% confidence interval 0.13 to 0.58) (52). A meta-analysis showed that 
folate supplementation can prevent recurrent NTD in 85% to 100% of cases(52). 
In a retrospective cohort study of births monitored by 13 birth defect registries from 1988 to 
1998 in Norway, Finland, Northern Netherlands, England and Wales, Ireland, France (Paris, 
Strasbourg, and Central East), Hungary, Italy (Emilia Romagna and Campania), Portugal, and 
Israel, cases of NTD were ascertained among liveborn infants, stillbirths, and pregnancy 
terminations (where legal)(108).  Main outcome measures included incidences and trends in 
rates of NTD before and after 1992 (the year of the first recommendations) and before and 
after the year of local recommendations (when applicable)(108).  The issuing of 
recommendations on folic acid was followed by no detectable improvement in the trends of 
incidence of NTD(108). The results were intriguing. It was concluded that recommendations 
alone did not seem to influence trends in NTD up to six years after the confirmation of the 
effectiveness of folic acid in clinical trials. New cases of NTD preventable by folic acid continue 
to accumulate(108). Authors concluded that a reasonable strategy would be to quickly 
integrate food fortification with fuller implementation of recommendations on 
supplements(108). Another study obtain a similar result: no detectable improvement in the 
trends of incidence of NTD in France, after recommendations on folic acid 
supplementation(116).  
There is no doubt that women at high risk of NTD benefit from higher doses of folic acid 
supplementation. These group includes women with certain folate-enzyme genotypes(117), or 
that smoke(117), alcohol abuse(118), malabsorption disorders(117, 118) or gastric 
bypass(118), haemolytic anaemia(118), liver disease(118), renal failure(118), those who take 
antifolate medications(117)(valproic acid, carbamazepine, trimethoprim, phenobarbital, 
primidone, diphenylhydantoin, oxcarbamazepine, sulphonamides, and methotrexate)(118), 
personal(117, 118) or family history of NTD(118), obesity(103, 117, 118), pre-gestational 
diabetes(103, 117, 118), epilepsy(118). 
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They should take 5 mg/day of folic acid for the 2 months before conception and during the first 
trimester(117). Other authors consider 4 mg/day(1). 
 
In a European study (with 22 925 women, aged 15–49 years, from 18 countries) was concluded 
that, of the respondents, 58% had at least one biological child, and of these 38% reported that 
their first pregnancy was not planned(119). Nearly 60% of women who planned their 
pregnancy indicated that they had stopped using their method of contraception without first 
consulting a physician or another health care professional(119). Overall, 70% reported that 
they had heard of folic acid and 40% stated that they knew the benefits of folic acid(119). 
However, when prompted to indicate which diseases and/or birth defects folic acid can protect 
against, only 17% knew that folic acid can reduce the risk of NTD/spina bifida(119). 
Regarding Portuguese situation, in a study about supplement use by pregnant women (from 
two major public hospitals in the North of Portugal, nearby 1998), it was concluded that a high 
proportion of women reported the use of folic acid (81.9%), iron (55.4%), and multivitamins 
(76.2%) as supplements during pregnancy(120). Higher schooling was also associated with 
increased use of folic acid. Use of folic acid was less prevalent in single women and during 
unplanned pregnancies(120). In a more recent study (nested within Geração XXI, a 
Portuguese birth cohort, who delivered in 2005-2006), 97% of women reported folic acid 
supplements use during the first trimester of pregnancy, although it is important to note that 
the median gestational age at initiation was 6.5 weeks (interquartile range 5-9)(13). 
In a study in Portugal, 77.5% of women aged 24-44 years knew about folic acid, but only 20% 
were able to describe folic acid as an effective method to reduce NTD and 15.4% of all 
respondents knew that supplementation with folic acid should begin before conception(80) 
In 2005, it was found an increase in the proportion of women taking folic acid prior to pregnancy 
since 1998. In 2005, 23.9% of women of the study took folic acid prior to pregnancy. There 
was a significant association between appropriate intake and the pregnancy being planned. In 
one survey, 54.5% of all women surveyed who had ever been pregnant reported having 
consulted a physician while preparing for their last pregnancy(121). 
Although the role of folic acid in NTD prevention is clear, many other questions arise. In 
consequence, the establishment of recommendations at a population level are not 
straightforward.  
 
Aim of the study 
This study aimed to summarize the recommendations on folate and folic acid in the 
periconceptional period provided by official health organizations in different countries 
worldwide. 
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METHODS 
Research about folate and folic acid recommendations for women in the periconceptional 
period was conducted in national health official websites of 46 countries worldwide: 33 
European2, including all 28 EU countries; 3 missing countries belonging to G83; all 5 BRICS4; 
all 4 Asian Tigers/ Asian Dragons5; and Australia. Developed countries were chosen due to 
the easiest access to data. Despite of that, data were unavailable or not found for 10 countries: 
8 European countries, being 6 from EU (Croatia, Cyprus, Czech Republic, Greek, Lithuania, 
Slovakia) and 2 not (Liechtenstein, Turkey); 1 BRICS (India); 1 Asian Dragon (South Korea). 
As a result, the total information was available for 36 countries (78%). The recommendations 
from the WHO were also investigated.  
For European countries the web addresses were obtained through the European Commission 
website, on the page entitled Public Health – Trustworthy websites on “Population 
groups”(122). The keywords used for researching in each country were the following: folic acid, 
folate, pregnancy, nutrition. The keywords and the information found were translated on 
Google® Translate, from English to the official languages and vice-versa. When information 
was unavailable at the referred website (it was the case of Ireland; Lithuania has no mention 
to any website; Denmark was missing) the research was made on Google®, adding another 
keywords: ministry of health, neural tube defects.  
From the websites of each country were registered recommendations for women in the 
periconceptional period concerning the following topics: folic acid supplementation for NTD 
risk reduction (dose, begin, end, upper limit, dose for high risk of NTD), folate recommended 
intake (measured in folate or in DFE), healthy diet and folate rich food, the website address, 
and the name of the official entity. 
For all countries e-mails were sent for validation of the information (59% were validated). In 
the validation process, the information was confirmed, corrected, and/or completed. From the 
36 countries with data, 26 countries validated the information (72%) and 10 did not (France, 
Latvia, Romania, Japan, Brazil, China, Russia, South Africa, Singapore, Taiwan). From the 
others 10 countries without data, only one (Liechtenstein) validated the (missing) information. 
The WHO have not validated data. Data without official validation were equally considered for 
results and analysis, after “internal validation” by beginning the researching process and 
conforming the data from the websites at least three times (corresponding to three different 
days). 
                                                   
2 EU: Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, 
Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, 
Sweden, United Kingdom. Some other European: Iceland, Liechtenstein, Norway, Switzerland, Turkey.  
3 G8: Canada, Japan, United States of America, and the other 5 countries mentioned both in EU (France, Germany, Italy, United 
Kingdom) and in BRICS (Russia). 
4 BRICS: Brazil, Russia, India, China and South Africa. 
5 Asian Tigers/ Asian Dragons: Hong Kong, Singapore, South Korea, Taiwan. 
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Websites were chosen instead of searching scientific articles with original information or 
revision of the official guidelines or instead of sending e-mails to each health country 
representative, because the revisions found didn’t have all the countries desired and because 
the propose was to know which information is available in the current year both for health 
professionals (guidelines) and for general public (Appendix 3). In the era of information, many 
people consult health recommendations trough the World Wide Web(123-125).  
Data were collected from May to October of 2013.  
All statistical analyses were performed with the IBM SPSS Statistics for Windows, Version 21.0 
(Released 2012. Armonk, NY: IBM Corp.). 
 
RESULTS 
Initially, it was tried to summarise information for 46 countries. However, for 10 countries 
(21.7%) information did not exist or it was not found. Data were available for 36 countries. The 
recommendations gathered are systematised in Tables 1 to 6 from countries and in Table 7 
from WHO. The majority (83.4%) of the analysed countries had some information in their 
national health official websites, about both folic acid supplementation and folate rich 
diet/healthy diet. Only few refers to supplementation alone (8.3%) or to diet alone (8.3%).  
In a general overview, from this studied were obtained the following main data related to folic 
acid supplementation for NTD risk reduction (higher percentages achieved are shown): 
 Dose: 400 µg/day (77.8%), discuss with healthcare provider (5.6%); 
 Begin: any period before conception (88.9%): at least 4 weeks (41.7%), at least 12 
weeks (11.1%), when planning a pregnancy (27.8%), when there is a chance of 
becoming pregnant (16.7%), before conception (11.1%), before stopping contraceptive 
(5.6%), when the contraceptive is stopped (5.6%); 
 End: first trimester (75.0%): 12 weeks (69.4%), 10 or 8 to 10 weeks (5.6%); throughout 
pregnancy (5.6%); 
 Upper limit: 1 mg/day (44.4%), not exceed recommendations (5.6%); 
 Dose for high risk of NTD: higher doses (58.3%): 5 mg (30.6%), 4 mg (13.9%), to be 
discussed with physician (8.3%). 
And data related to folate (higher percentages obtained are shown): 
 Is healthy diet and folate rich food recommended? Yes (80.6%): healthy diet may be 
enough (no need of supplementation) (13.9%); 
 Folate recommended intake: Nordic Nutrition Recommendations (16.7%): pregnant 
500 µg/day, women 18-30 years or childbearing age 400 µg/day, women 300 µg/day.  
 DFE recommended intake: DRI (16.7%): pregnant 600 µg/day, women 400 µg/day; 
German language D-A-CH (8.3%): pregnant 550 µg/day; women 300 µg/day; higher 
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intake of folate only after first trimester (5.6%): pregnant second and/or third trimester 
600 µg/day, women 400 µg/day. 
It was observed that the recommendations differ between countries, although the majority 
(63.9%) recommend 400 µg of folic acid at least one to three months before conception until 
three months of pregnancy. In Portugal there are no official recommendation of the dose that 
should be taken. There was a consensus in the recommendation of a healthy diet, naturally 
rich in folate.  
Worldwide, the daily folate recommended intake for pregnant women could be summarised in 
three different recommendations: 500 µg of folate (from Nordic Nutrition Recommendations), 
550 µg of DFE (from D-A-CH recommendations – dominant states of the German language 
Sprachraum), and 600 µg of DFE (from Institute of Medicine). Two countries recommend only 
a higher intake of folate after the first trimester of pregnancy, being 400 µg for women of 
childbearing age and pregnant women in the first trimester. For high risk women, 
recommendations are high, mostly 4 mg and 5 mg. 
Some countries emphasize the importance of a healthy diet naturally rich in folate with no need 
of folic acid supplementation. By contrast, others advice supplementation (one on very high 
doses) plus mandatory folic acid fortification. The upper limit of folic acid intake is considered 
1 mg by many countries. Many guidelines consider that recommendations may change with 
new research, to meet the optimum level and not supraphysiologic levels that may have 
adverse effects.  
In what concerns the USA different recommendations were found (in one it was referred that 
folic acid could be taken from supplements or fortified foods, another should be from 
supplements; one referred a dosage of 400 µg/day, another 400-800 µg/day). Out of this 
general pattern were Canada and China (400 µg/day of folic acid supplements in the 
periconceptional period, but also recommends supplementation throughout pregnancy), and 
Brazil (recommended a dosage of 5 mg, particularly in women with history of NTD). The others 
countries (25.0%) – Ireland, Portugal, Romania, Slovenia, Japan, Russia, South Africa, 
Singapore, Taiwan –, have at least one missing data in the mentioned characteristics. BRICS 
was the only group completely out of the general pattern (out or missing data), all the others 
(Europe, EU, Asian Tigers, G8, and Australia) had at least one country in the general pattern.  
Concerning WHO, it almost fits the general pattern, being missing the advice for a healthy 
diet/folate rich diet, mentioned only in the topic for high risk women (advised to increase their 
food intake of folate and to take 5 mg of folic acid daily).  However, considering another 
available document of the same institution, made with the purpose of improving pregnancy 
outcomes and reduce maternal anaemia, it is out of the pattern (400 µg/day of folic acid 
supplements periconceptionally and throughout pregnancy). 
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Some particularities were observed in some countries, described below.  
From the analysed countries, five had mandatory fortification. 
The only country that recommended doses between 400 µg/day and 800 µg/day was USA. 
Brazil was not completely clear in the recommendation about dose and about the target: 
recommended 5 mg/day especially in women with history of NTD. 
At least one country (Denmark) changed the designation about the period to begin folic acid 
supplementation, from “when planning” to “when start thinking about getting pregnant” or 
“before conception” or “when there is a chance of becoming pregnant”, because almost half 
pregnancies are not planned. 
The countries that specially emphasized healthy diet (where the need of supplementation was 
not generalized) were: Finland, France, Sweden, Singapore, and Taiwan.  
Only one country (Singapore) mentioned, in information for general population, the importance 
of folate status, which should be achieved by a healthy diet and gave examples of folate rich 
foods. Also recommended to check with the healthcare provider the need of taking 
supplements containing folate. 
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Table 1. Folate and folic acid recommendations for women in the periconceptional period from national health organizations official websites of some EU 
countries (n=22). 
Country Folic acid supplementation for NTD risk reduction Is healthy diet 
and folate rich 
food 
recommended? 
Folate 
recommended 
intake  
DFE 
recommended 
intake 
Website ‡ 
Dose Begin End Upper limit Dose for high 
risk of NTD 
Austria 400 
µg/day 
At least 4 weeks/ 
1 month before 
conception 
12 weeks/ 3 
months of 
pregnancy 
1 mg/day for 
adults  
(D-A -CH 2013) 
Higher doses 
(>400 
µg/day)/ to 
discuss with 
physician 
(D-A -CH 2013) 
Yes 
 
- Pregnant 550 
µg/day 
Women 300 
µg/day 
(D-A -CH 2013) 
Federal Ministry of Health – 
Public health portal 
Belgium – 
Flanders 
400 
µg/day 
When the 
contraceptive is 
stopped 
12 weeks/ 3 
months of 
pregnancy 
1 mg/day 
for adults 
4 mg/day 
 
Yes - - 
 
Flemish government – 
 Child and Family 
Support Centre for Policy 
Research – Welfare, Health 
and Family 
Bulgaria 400 
µg/day 
At least 12 
weeks/ 3 months 
before 
conception 
12 weeks/ 3 
months of 
pregnancy  
 
- - Yes 
 
- - 
 
The official Bulgarian patient 
organization Zachatie/ 
Conception Bulgarian portal * 
Denmark 400 
µg/day 
When start 
thinking about 
getting pregnant 
** 
 
12 weeks/ 3 
months after 
conception 
 
or  
8 weeks/ 2 
months (for 
high risk of 
NTD) 
Not exceed 
recommendation 
5 mg 
prescribe by 
the physician 
 
Yes 
 
Pregnant  
500 µg/day  
Women 18-30 
years or 
childbearing 
age 
400 µg/day 
Women 
300 µg/day 
(NNR 2012) 
- Danish Health and Medicines 
Authority 
 
 
 
Nordic Nutrition 
Recommendations 
 
 
Estonia 400 
µg/day 
 
 
At least 12 
weeks/ 3 months 
before 
conception 
12 weeks/ 3 
months of 
pregnancy 
1 mg/day 
for adults 
4 mg/day Yes 
 
Pregnant  
500 µg/day  
Women 18-30 
years or 
childbearing 
age 
400 µg/day  
Women 
300 µg/day  
- National Institute for Health 
Development 
 
Health Information Network 
 
Treatment Guide 
‡The corresponding web addresses are listed in Appendix 3. .- Blank mean that no information was available.  
EU: European Union. NTD: Neural Tube Defects. DFE: Dietary Folate Equivalents. D-A-CH: reference values for nutrient intake by German Society of Nutrition, the Austrian Society of Nutrition, the 
Swiss Society of Nutrition Research and the Swiss Association of Nutrition. NNR: Nordic Nutrition Recommendations (by Denmark, Finland, Iceland, Norway, and Sweden).  
* The referred article is just an article on the site and nothing more. The information on our site (which is the site of the official Bulgarian patient organization Zachatie) is a collection of Bulgarian and 
translated articles, approved by our medical editor. These are not medical standards. Therefore, the information contained wi thin may vary (information received by e-mail, 2013-10). 
** Early we said “when you plan to get pregnant” but not all pregnancies are planned ( information received by e-mail, 2013-10).  
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Table 1. Folate and folic acid recommendations for women in the periconceptional period from national health organizations official websites of some EU countries (n=22) (continuation). 
Country Folic acid supplementation for NTD risk reduction Is healthy diet 
and folate rich 
food 
recommended? 
Folate 
recommended 
intake  
DFE 
recommende
d intake 
Website‡ 
 Dose Begin End Upper limit Dose for high 
risk of NTD 
Finland 400 µg/day 
 for woman 
with an 
unhealthy diet 
*** / **** 
When the 
contraceptive is 
stopped / for those 
who plan to 
become pregnant 
12 weeks/ 3 
months of 
pregnancy 
1 mg/day 
for adults 
4 mg/day 
 
Yes 
*** / **** 
Pregnant  
500 µg/day  
Women 18-30 
years or 
childbearing age 
400 µg/day 
Women 
300 µg/day 
(NNR 2012) 
- Ministry of Social Affairs and 
Health 
 
Nordic Nutrition 
Recommendations 
France 400 µg/day 
may be 
prescribed by  
healthcare 
provider  
*****  
At pregnancy 
project 
12 weeks/ 3 
months of 
pregnancy 
- 5 mg/day Yes ***** 
 
- - National Institute for 
Prevention and Health 
Education 
National Nutrition and Health 
Program 
Germany 400 µg/day At least 4 weeks/ 1 
month before 
conception 
12 weeks/ 3 
months of 
pregnancy 
1 mg/day for 
adults  
 
To discuss 
with physician 
Yes 
 
- Pregnant  
550 µg/day  
Women  
300 µg/day  
(D-A -CH 2013) 
Federal Centre for Health 
Education – Family planning  
 
German Society for Nutrition 
Hungary 400 µg/day At least 4 weeks/ 1 
month before 
conception 
12 weeks/ 3 
months of 
pregnancy 
- - Yes 
 
- - National Centre for Food 
Safety and Nutrition 
Ireland 400 µg/day 
 
12 weeks/ 3 
months before 
conception / all 
women of 
childbearing age 
12 weeks/ 3 
months of 
pregnancy 
- 5 mg/day - - - Health Service Executive 
Italy 400 µg/day 
 
Before conception 
 
12 weeks/ 3 
months of 
pregnancy 
- 5 mg/day 
****** 
Yes 
 
- - Ministry of Health 
Latvia  400 µg/day 
 
While trying to get 
pregnant 
12 weeks/ 3 
months of 
pregnancy 
- - Yes 
 
- - Latvian Health Portal 
Luxemburg 400 µg/day 
 
4 weeks/ 1 month 
before conception 
12 weeks/ 3 
months of 
pregnancy 
- Higher doses 
(>400 µg/day) 
Yes 
 
- - Ministry of Health 
 
‡The corresponding web addresses are listed in Appendix 3. .- Blank mean that no information was available. EU: European Union. 
*** Unhealthy diet means having less than 400 µg of folate. Supplementation is also recommended for women with other problems (e.g., epilepsy, celiac disease, diabetes mellitus insulin dependent).  
**** Similar to new recommendations that will be launched in 2014. The rationale is that the most critical period for sufficient folic acid intake is during the period when the women actually do not even 
know that they are pregnant. In Finland healthy diet which includes rye bread, berries and green leafy vegetables which is recommended for all, provides sufficient amount of nutrients. Finland healthy 
diet provides sufficient amount of nutrients (information received by e-mail, 2013-10). ***** A varied diet may be enough, although, for precaution, the healthcare provider may prescribe a supplement. 
****** The dose of 5 mg (instead of 4 mg as suggested by the evidence of efficacy) is indicated because in Italy does not have a formulation of 4 mg of folic acid per tablet. 
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Table 1. Folate and folic acid recommendations for women in the periconceptional period from national health organizations official websites of some EU countries (n=22) (continuation). 
Country Folic acid supplementation for NTD risk reduction Is healthy diet 
and folate rich 
food 
recommended
? 
Folate 
recommended intake  
DFE 
recommended 
intake 
Website‡ 
 Dose Begin End Upper limit Dose for 
high risk of 
NTD 
Malta 400 µg/day Women who are 
planning a 
pregnancy/ prior to 
conception 
12 weeks/ 3 
months of 
pregnancy 
1 mg/day 
for adults 
- Yes - - 
Women 400 µg 
Ministry for Health 
Netherlands 400 µg/day  
or 
500 µg/day 
4 weeks/ 1 month 
before conception / 
when there is a 
chance of becoming 
pregnant 
10 weeks/ 2 
months of 
pregnancy 
- Higher 
doses 
(>400 
µg/day  
or 500 
µg/day) 
Yes 
 
- - National Institute for 
Public Health and 
Environment – 
Ministry of Health, 
Welfare and Sport 
Nutrition Centre 
Poland 400 µg/day While trying to get 
pregnant 
12 weeks/ 3 
months of 
pregnancy 
- - Yes - - Ministry of Health 
Portugal - At least 8 weeks/ 2 
months before stop 
using contraception 
- - - Yes 
 
- - Ministry of Health 
Romania 400 µg/day - - 1 mg/day 
for adults 
5 mg/day Yes 
 
- Pregnant 3rd trimester 
600 µg/day 
Women 400 µg/day 
Ministry of Health – 
Romanian Nutrition 
Society 
Slovenia - - - - - Yes 
 
- Pregnant 2nd and 3rd  
trimester  600 µg/day  
Women 400 µg/day  
(D-A -CH 2004) 
Institute of Public Health 
of the Republic of 
Slovenia 
Ministry of Health 
Spain 400 µg/day 12 weeks/ 3 months 
before stop 
contraception/ 
4-8 weeks/ 1-2 
months before 
conception******* 
12 weeks/ 3 
months of 
pregnancy 
1 mg/day 
for adults 
5 mg/day 
******* 
Yes - - Ministry of Health, 
Social Services and 
Equality – National 
Health System 
Sweden 400 µg/day 
except for 
women with 
high folate 
intake 
******** 
4 weeks/ 1 month 
before conception / 
woman who may get 
pregnant 
12 weeks/ 3 
months of 
pregnancy 
1 mg/day 
for adults 
- Yes 
 
Pregnant  
500 µg/day  
Women 18-30 years 
or childbearing age 
400 µg/day 
Women 300 µg/day  
(NNR 2012) 
- National Food Agency 
Nordic Nutrition 
Recommendations 
European Food Safety 
Authority 
United 
Kingdom 
400 µg/day While trying to get 
pregnant 
12 weeks/ 3 
months of 
pregnancy 
- 5 mg/day Yes 
 
- - National Health Service 
 
‡The corresponding web addresses are listed in Appendix 3. .- Blank mean that no information was available. EU: European Union.  
******* According to new guidelines, in press, 2013. ******** For women with a high intake of folate-rich foods, such as vegetarians and vegans eating large quantities of pulses and vegetables, folate 
intake from food may happen to be enough. For them there is no need for extra folic acid supplementation.  
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Table 2. Folate and folic acid recommendations for women in the periconceptional period from national health organizations official websites of some others 
European countries (n=3). 
Country Folic acid supplementation for NTD risk reduction Is healthy diet 
and folate rich 
food 
recommended? 
Folate 
recommended 
intake  
DFE 
recommended 
intake 
Website‡ 
Dose Begin End Upper limit Dose for high 
risk of NTD 
Iceland 400 
µg/day 
 
At least 4 weeks 
before 
conception/ 
all women able to 
get pregnant 
12 weeks/ 3 
months of 
pregnancy 
- 5 mg/day Yes 
 
Pregnant  
500/day µg  
Women 18-30 
years or 
childbearing age 
400/day µg 
Women 
300/day µg 
(NNR 2012) 
- Directorate of Health 
 
 
Nordic Nutrition 
Recommendations 
Norway 400 
µg/day 
4 weeks/ 1 month 
before conception 
/ women who are 
planning to 
conceive 
8-12  weeks / 
2-3 months of 
pregnancy 
- 4 mg/day Yes 
 
Pregnant  
500/day µg  
Women 18-30 
years or 
childbearing age 
400/day µg 
Women 
300/day µg 
(NNR 2012) 
-  National Institute of Public 
Health 
 
Nordic Nutrition 
Recommendations 
Switzerland 400 
µg/day 
 
 
Women who wish 
or may fall 
pregnant/  
At least 4 weeks/ 
1 month before 
conception 
12 weeks/ 3 
months of 
pregnancy 
 
 
1 mg/day 
for adults 
(D-A -CH 2013) 
Higher doses 
(>400 
µg/day)/ to 
discuss with 
physician 
(D-A -CH 2013) 
Yes - Pregnant  
550 µg/day 
Women  
300 µg/day 
(D-A -CH 2013) 
Federal Office of Public 
Health * 
 
Swiss Society of Nutrition 
‡The corresponding web addresses are listed in Appendix 3. 
- Blank mean that no information was available. NTD: Neural Tube Defects. DFE: Dietary Folate Equivalents. 
D-A-CH: an acronym used to represent the dominant states of the German language Sprachraum, and are reference values for nutrient intake by German Society of Nutrition, the Austrian Society of 
Nutrition, the Swiss Society of Nutrition Research and the Swiss Association of Nutrition. 
*According to official information from Swiss Society of Nutrition, the new D-A-CH recommendations will be online in the website, and are already in practice (information received by e-mail, 2013-10). 
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Table 3. Folate and folic acid recommendations for women in the periconceptional period from national health organizations official websites of some G8 
countries (n=3). 
Country Folic acid supplementation for NTD risk reduction Is healthy diet 
and folate rich 
food 
recommended? 
Folate 
recommended 
intake  
DFE 
recommended 
intake 
Website‡ 
Dose Begin End Upper limit Dose for 
high risk of 
NTD 
Canada + 400 µg/day 
(by 
supplements)  
At least 12 
weeks/ 3 months 
before conception 
Throughout the 
pregnancy 
1 mg/day 
for adults 
 
 
Higher doses  
(1-5 mg/day) 
Yes 
 
- Pregnant  
600 µg/day 
Women  
400 µg/day 
Health Canada 
Japan - 12 weeks/ 3 
months before 
conception 
12 weeks/ 3 
months of 
pregnancy 
- - - - - Ministry of Health, Labour 
and Welfare 
United States 
of America + 
400 µg/day  
(by 
supplements 
or fortified 
food)  
Or 400-800 
µg/day (by 
supplements) 
At least 4 weeks/ 
1 month before 
conception/ all 
women able to 
get pregnant 
During the first 
few months 
1 mg/day 
for adults 
4 mg/day Yes 
 
- Pregnant  
600 µg/day 
Women  
400 µg/day 
Centers for Disease Control 
and Prevention 
Institute of Medicine of the 
National Academies 
 
Women’s health – 
Department of Health and 
Human Service 
‡The corresponding web addresses are listed in Appendix 3. + Country with mandatory fortification(19). 
- Blank mean that no information was available. NTD: Neural Tube Defects. DFE: Dietary Folate Equivalents. 
Note: The Group of Eight (G8) is a forum for the governments of eight of the world's largest national economies as nominal Gross Domestic Product (GDP) with higher Human Development Index 
(HDI): Canada, France, Germany, Italy, Japan, Russia, United Kingdom, and USA. EU is also represented. 
 
 
Table 4. Folate and folic acid recommendations for women in the periconceptional period from national health organization official website of Australia (n=1). 
Country Folic acid supplementation for NTD risk reduction Is healthy diet 
and folate rich 
food 
recommended? 
Folate 
recommended 
intake  
DFE 
recommended 
intake 
Website‡ 
Dose Begin End Upper limit Dose for 
high risk of 
NTD 
Australia + 400 µg/day 
(by 
supplements) 
At least 4 weeks/ 
1 month before 
conception /  
women planning 
a pregnancy 
12 weeks/ 3 
months of 
pregnancy 
1 mg/day 
for adults 
5 mg/day Yes 
 
- Pregnant  
600 µg/day 
Women  
400 µg/day 
National Health and Medical 
Research Council 
 
Food Standards Australia 
New Zealand 
‡The corresponding web addresses are listed in Appendix 3. + Country with mandatory fortification(19). 
- Blank mean that no information was available. NTD: Neural Tube Defects. DFE: Dietary Folate Equivalents.  
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Table 5. Folate and folic acid recommendations for women in the periconceptional period from national health organizations official websites of some BRICS 
countries (n=4). 
Country Folic acid supplementation for NTD risk reduction Is healthy diet 
and folate rich 
food 
recommended? 
Folate 
recommended 
intake  
DFE 
recommended 
intake 
Website‡ 
Dose Begin End Upper limit Dose for 
high risk of 
NTD 
Brazil + 5 mg/day 
especially in 
women with 
history of 
NTD 
8-12 weeks/ 2-
3 months 
before 
conception 
 
- - 5 mg/day - - - Ministry of Health 
China 400 µg/day At least 4 
weeks/ 3 
months before 
conception 
Throughout the 
pregnancy  
1 mg/day 
for adults 
- Yes - Pregnant 
600 µg/day 
Women  
400 µg/day 
E-health – Shanghai Jing’an 
District Health Promotion 
Board – Ministry of Health 
Chinese Nutrition Society 
Russia - - - 1 mg/day 
for adults 
- Yes - Pregnant 
 600 µg/day 
Women 400 
µg/day 
Ministry of Health of the 
Russian Federation 
Protection and Human 
Welfare 
South Africa 
+ 
- Women of 
reproductive 
age 
- Not exceed 
recommendation 
- Yes - - The National Department of 
Health 
Association for Dietetics in 
South Africa 
‡The corresponding web addresses are listed in Appendix 3. + Country with mandatory fortification(19). 
- Blank mean that no information was available. NTD: Neural Tube Defects. DFE: Dietary Folate Equivalents.  
Note: BRICS is the acronym for an association of five major emerging national economies: Brazil, Russia, India, China and South Africa. 
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Table 6. Folate and folic acid recommendations for women in the periconceptional period from national health organizations official websites of some Asian 
Tigers/ Asian Dragons countries (n=3). 
Country Folic acid supplementation for NTD risk reduction Is healthy diet 
and folate rich 
food 
recommended? 
Folate 
recommended 
intake  
DFE 
recommended 
intake 
Website‡ 
Dose Begin End Upper limit Dose for high 
risk of NTD 
Hong Kong 400 
µg/day 
4 weeks/ 1 month 
before conception 
/ when planning 
for pregnancy 
12 weeks/ 3 
months of 
pregnancy* 
- 
 
- Yes - - Department of Health 
The Hong Kong College of 
Obstetricians and 
Gynaecologist 
Singapore -** 
Check with  
healthcare 
provider 
Before conception 
  
12 weeks/ 3 
months of 
pregnancy 
- - Yes** - Pregnant 
600 µg/day 
Women  
400 µg/day 
Health Promotion Board – 
Singapore Government 
Taiwan -*** -  - 1 mg/day - Yes*** 
 
Pregnant 
600 µg/day 
Women  
400 µg/day 
 - Ministry of Health and 
Welfare: 
Health Promotion 
Administration; 
Food and Drug Administration 
‡The corresponding web addresses are listed in Appendix 3. 
- Blank mean that no information was available. NTD: Neural Tube Defects. DFE: Dietary Folate Equivalents. 
Note: the Asian Tigers or Asian Dragons is a term used in reference to the highly developed economies of Hong Kong, Singapore, South Korea, and Taiwan.  
* Folic acid supplementation should be continued in women carrying thalassemia trait to prevent folic acid deficiency and maternal anaemia. 
** It is important to ensure an adequate intake of folate even prior to conception. Keep up your folate status by eating a diet that includes rich sources of folate, such as green leafy vegetables, lentils 
and fortified products. Also, check with your healthcare provider on the need of taking supplements containing folate.  
*** In order to ensure that there is sufficient folate for the baby’s development, the best method is to consume foods high in folate on a frequent basis, such as green vegetables, fruits, fresh orange 
juice, liver. A balanced diet is assumed to be enough to achieve the recommendations. 
 
Table 7. Folate and folic acid recommendations for women in the periconceptional period from World Health Organization website (n=1). 
Entity Folic acid supplementation for NTD risk reduction Is healthy diet 
and folate rich 
food 
recommended? 
Folate 
recommended 
intake  
DFE 
recommended 
intake 
Website‡ 
Dose Begin End Upper limit Dose for high 
risk of NTD 
World Health 
Organization 
400 
µg/day* 
As early as 
possible* 
(periconceptionally) 
Throughout 
pregnancy* 
- - Yes - - World Health Organization 
 
 
400 
µg/day** 
Women trying to 
conceive at 8 
weeks/ 2 months 
before the planned 
pregnancy** 
12 weeks/ 3 
months of 
pregnancy** 
 
- 5 mg** / *** Yes for high 
risk **/*** 
- - 
‡The corresponding web addresses are listed in Appendix 3. 
- Blank mean that no information was available. NTD: Neural Tube Defects. DFE: Dietary Folate Equivalents. *Purpose: improving pregnancy outcomes and reducing maternal anaemia in pregnancy(9). 
** Aim: to prevent NTD and other congenital malformations in the fetus(10). *** For women who have previously had a baby with NTD, who have diabetes or who are under anticonvulsant treatment. 
*** High risk: advise to increase their food intake of folate.
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DISCUSSION 
The association between adequate maternal folate levels during the periconceptional period 
and the reduction in the congenital defects, especially NTD is completely establish. However, 
warrant an adequate folate status in this period is a challenge worldwide, according to prior 
studies (3, 8, 11). To fill this gap, WHO and many national health organizations have been 
developing recommendations related to folic acid supplementation and folate rich diet. Some 
countries also implemented mandatory folic acid fortification. 
In Public Health it is indispensable to widespread clear and unique messages among health 
professionals and general public that is more and more interested in to judge the information 
provided by health professionals. 
The question of folate adequacy seeking congenital anomalies prevention is very interesting, 
because the critic period for that adequacy is the first 6 gestational weeks when the majority 
of women unknown their pregnancies, even in the planned pregnancies (exceptions would be 
the pregnancies medical assisted). Ideally, a correct diet would supply adequate intakes, but 
this is not the reality(13). Supplementation could be a natural solution for this deficiency. 
However, regarding this special scenario, food fortification in folate appears as a better 
solution, providing adequate folate intakes, without any voluntary attitude taken by women. So, 
recommendations should be a clear message regarding at least two of the three possibilities 
of sources for an adequate folate intake – diet and supplements. Fortification is restricted for 
countries that opted for this measure. 
Nowadays, World Wide Web is available for the majority of the population in many countries 
worldwide. This is an excellent vehicle for given messages for health professionals and 
population. For this reason, this source of information was used. 
Initially, it is intended to obtain information for 46 countries, but for 10 of them it was impossible 
to reach any information. For the other 36 countries diverse information was obtained. 
Obviously that it should have differences among countries regarding different dietary patterns 
and different diseases prevalence, but probably there is not a clear rational justification for the 
disparities between countries. Inclusively, differences in the recommendations for the same 
country (USA) were found. This situation is completely undesirable regarding the doubt that 
could arise in the population. 
A huge amount of work should be done regarding dietary advice. For instance, in the Portugal, 
a healthy diet was recommended without specify many details. This type of message is clearly 
insufficient for the population. Detailed recommendations regarding type of foods, methods of 
cooking and quantities would be very useful. It is important to note that the information about 
a healthy diet was not in the same document that contains the guidelines for health 
professionals regarding preconception advices, which mention the time to begin folic acid 
supplementation (but not to stop, neither dose nor diet). Furthermore, the document about diet 
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refers a dose of 400 µg/day as a reference for folic acid intake, but this was not a guideline, 
neither has an official format, nor authors, but can be consulted by Internet users. 
 
The recommendations differ between countries, although the majority (66.7%) recommend 
400 µg/day of folic acid supplements in the periconceptional period and a folate rich diet. Some 
countries emphasize the importance of a healthy diet naturally rich in folate with no need of 
folic acid supplementation. According to many studies, mentioned in the introduction(72), this 
advice should be the main in all recommendations for NTD prevention. By contrast, others 
advice supplementation and have mandatory folic acid fortification. In Portugal there is no 
official recommendation of the amount that should be taken. 
The current study found that the designations to mention the adequate period for 
supplementation vary between countries. It can considered the more adequate the ones that 
included the general designation “before conception” and that refers to “planning plus chance 
of becoming pregnant”, although this needs a specific study to see this information if is correctly 
interpreted. The only designation that seemed less precise is “reproductive age”, because 
many women may belong to this group but not have “chance to get pregnant”, so they may not 
need to have supplementation. Although this group is the main general target of all countries, 
is not the specific target. 
Comparing folate recommendations, DRI had higher recommendations than D-A-CH or NNR. 
The last seems more realistic to achieve throw a normal healthy diet, as shown by Table 2 (in 
the general Introduction). 
Apart from recommendations about supplementation, some countries introduced fortification 
and others not. Surprisingly, in one of the countries with mandatory supplementation (Brazil) 
were recommended in general high doses of folic acid (5 mg) and not only for high risk of NTD. 
Although the guideline refers “especially in women with history of NTD”, it is not an easy 
understandable statement. In the research made for Brazil, it was found other 
recommendations, but not officially from ministry of health, for this reason it was not included 
in the analysed tables. It was from University Maternity of Rio de Janeiro6, where it was advised 
400 µg/day (by supplements) and 4 mg for high risk of NTD. We also did not find a clear 
justification for the recommendation of 5 mg of folic acid exclusively for Brazil. But, once again, 
we cannot warrant that these doses were not practiced in other countries, as it as mentioned. 
It is not easy to know the real intake of folic acid in different countries, because some scientific 
studies limit this kind of information, providing only the proportion of supplemented women 
without refers the dose. 
 
 
                                                   
6 http://www.maternidade.ufrj.br/portal/images/stories/pdfs/ob stetricia/consulta_pre_concepcional.pdf  (information for health professionals). 
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It is interesting to note that all the mandatory fortified countries also recommended 
supplementation and any refers that diet may be enough. By contrast, the only two groups 
(European and Asian) without mandatory fortification in all their analysed countries, are the 
same that consider diet to be enough (by some countries) and that mentioned the importance 
to discuss supplementation with the physician or health provider (by some countries). 
 
Apart from recommendations, from this research it is not possible to assume that the 
recommendations are effectively implemented. Particularly for Portugal, the recommendations 
from ministry of health do not specify the dose for the supplementation, but from Infomed (126) 
website,  we knew that are only commercialized doses with 5 mg of folic acid, for supplements 
containing only folic acid. The most of multivitamins have 400 µg of folic acid and some 
combinations of folic acid and iron supply 1 mg of folic acid (recommended for second and 
third trimesters of pregnancy). The folic acid dose of 5 mg/day is even higher than UL. The 5 
mg and 1 mg (in combination with iron) are reimbursed by the government in 37% (126), the 
others not. We don’t know why in Portugal are only commercialized high doses. 
Spain and Malta also had had available high doses, but they already changed the posology of 
the commercialized drugs, to adjust for NTD prevention (and not for megaloblastic anaemia 
treatment, as this doses were used for). Portugal did not change yet. 
Returning Portuguese situation, it was shown by data from INFARMED7(127) an increased 
waiver of folic acid in the last 12 years (2000-2012), with a linear tendency, from 215,308 packs 
in 2000 to 388,213 packs in 2002, representing an increase of 80.3% in this period of time, 
with an average perceptual change (AVC) of 5.2% per year. But has data is aggregated and 
cannot be separated by groups of supplements users, no conclusion can be taken. Only 
discuss that if population didn’t change in the same proportion(128, 129) to justify this rise, 
others factors may explain, being the begging of the supplementation in 1998(130, 131) a 
possible reason, that needs confirmation. Data can be analysed (some available at 
Eurocat(121)), and compared incidence and prevalence before and after supplementation. 
Accurate health registries would be very useful in order to measure the impact of such 
recommendations. For instance, regarding congenital anomalies, it would be necessary 
information regarding miscarriages, medical abortions, stillbirths and neonates with congenital 
information, information not always easy to aggregate. 
 
                                                   
77 Data from Autoridade Nacional do Medicamento e Produtos de Saúde, I.P. The information is from the SIARS (Sistema de 
Informação da Administração Regional de Saúde / Information System of the Regional Health Authority) and may be subject to 
alteration. The data refer to the reimbursed medicines and dispensed in an outpatient population covered by the National Health 
Service in the period from January 1, 2000 to December 31, 2012, in Portugal. In this universe are not included medicines related 
to hospitalization (information sent by e-mail, 2013-10). 
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CONCLUSION 
Folic acid recommendations worldwide in the periconceptional period are predominantly of 400 
µg/day, despite the fact that the epidemiology of the neural tubes defects is different between 
countries, as folate intake. However, big disparities were seen for the recommendations of 
some countries – at least one country recommend 5 mg of folic acid and, in contrast, some do 
not recommend supplementation, only a healthy diet.  
In Portugal no dose is officially recommended, although the only commercialized doses of folic 
acid (alone, not in multivitamins) are of 5 mg, so women with low risk are taken doses above 
the UL for folate. Accurate and, ideally, evidence-based recommendations are needed for 
Portugal.  
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CHAPTER 2 – FOLATE INTAKE AND FOLIC ACID SUPPLEMENTATION IN THE 
PERICONCEPTIONAL PERIOD: DIFFERENT APPROACHES FOR ITS MEASUREMENT 
INTRODUCTION 
It is consensual that maternal diet during pregnancy influences maternal and child health(132). 
Folate deficiency is strongly associated with neural tube defects (NTD)(133), but dietary folate 
was not clearly associated with the reduction of NTD risk(8), contrasting with folic acid 
supplementation(3, 134) and, consequently, widely recommended in the periconceptional 
period(3).  
Regarding risk reduction of NTD, folic acid supplementation should be initiated in the pre-
pregnancy period(11, 108, 132, 135, 136). According to DRI (3, 8)., women capable of 
becoming pregnant should take 400 µg of folic acid daily from fortified foods, supplements, or 
both, in addition to the folate consumption from a varied diet, until their pregnancy is confirmed 
and their enrolment in the prenatal care (which ordinarily occurs after the critical time for the 
formation of the neural tube, that closes by day 28 after conception). These recommendations 
are impossible to be followed in unplanned pregnancies, and even in planned pregnancies, 
frequently, the supplementation initiated about the week 6  of pregnancy(13, 108). 
Concerning DFE, DRI establishes that women in the childbearing age should intake 400 
µg/day DFE, increasing to 600 µg/day DFE during pregnancy(3). It is important to note that 
risk reduction for NTD was not a “cornerstone” in this values definition. A separate 
recommendation, mentioned above, was presented and discussed(3). 
A previous study in Portuguese pregnant women determined that 58.2% of them consumed 
inadequate quantities of folate previous to conception (median daily intake: 293.5 µg; 
interquartile range: 239.4-380.1 µg) and this proportion ascended to 90.8% during pregnancy 
(median daily intake: 314.6 µg; interquartile range: 245.1-400.8 µg), considering the Estimated 
Average Requirements (EAR) of 320 µg/day and 520 µg/day, respectively, as cut-off points for 
folate intake alone(13). In the same study, authors documented that although almost all women 
took folic acid supplements during first pregnancy trimester, the median age at initiation was 
6.5 weeks of pregnancy, certainly after the closure of neural tube, when it is a decisive role(13). 
The inadequacy intake in folate is also described in others populations(137, 138). 
In order to determine the inadequacy of folate intake, it is indispensable to have tools that 
accurately quantify folate intake and, ideally, to know what is the relationship between folate 
intake in its blood levels. Then we could really associate maternal nutritional status with 
pregnancy outcomes, in early and later in life, both in child and mother. 
There are different tools to access dietary intake, however none is perfect, being into account 
the complexity of the diet. In the selection of one method, it would be considered the population 
characteristics and the sample size.  
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Food frequency questionnaire (FFQ) is one of the tools more frequently used in 
epidemiological studies involving a large number of participants, due to economical and logistic 
reasons and for its ability to reflect usual dietary intake of a large period of time(139-145). 
A semi-quantitative FFQ was validated to measure dietary intake in Portuguese pregnant 
women, using as a gold standard food diaries (FD)(146). Another possibility in the validation 
of dietary questionnaires is the use of biomarkers, in this case serum/plasma and/or 
erythrocyte folate levels(139, 147, 148). 
The advantage of using biochemical markers in dietary assessments is related with the low 
probability to doubt that their random errors are truly independent of those of food 
questionnaires(147). Biomarkers retrieve the nutrient quantities available for biological 
processes and depend on the balance between intake and nutrient’s metabolism. This 
metabolism could range between individuals. For instance, in subjects with the MTHFR 677 
T/T genotype  folate intake was not correlated with plasma levels(142).  
Although some studies have been associated dietary folate intake with respective 
serum/plasma or erythrocytes levels, few considered both dietary folate and folic acid 
supplements intake(149, 150). However, regarding pregnancy population, especially in the first 
pregnancy trimester, this supplementation is very frequent.   
 
Aim of the study 
The main objective of this study was to estimate the association between folate intake and folic 
acid supplementation (measured through a semi-quantitative FFQ, a FD and a questionnaire 
about vitamins supplements intake) in the periconceptional period and folate status (through 
serum folate and erythrocyte folate) in early pregnancy. As secondary objective, we aimed to 
establish socio-demographic determinants of an adequate intake of folic acid supplements in 
the periconceptional period.   
 
METHODS  
This study was developed in Department of Clinical Epidemiology Predictive Medicine and 
Public Health from the University of Porto with the collaboration of the Obstetrics and 
Gynaecology Department of Hospital S. João (Porto, Portugal).  Women’s recruitment 
occurred between December 2007 and December 2008. The study was submitted and 
approved by the Ethics Committee of the hospital S. João. In the first contact, participants 
signed a written informed consent. 
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Participants 
Pregnant women were invited at first trimester ultrasound or in the prenatal visits (gestational 
age approximately of 12 weeks) at Obstetrics and Gynaecology Department of Hospital S. 
João, consecutively. During this first contact, all women with diabetes(103, 117, 118) or 
hypertension or taking anticonvulsants(3) or sulfasalazine(3) were excluded, since all these 
conditions can affect folate and folic acid metabolism. This situation was carefully explained to 
women excluded. 
For all women who filled inclusion criteria, the aims of the study were explained, the 
participation was formalized by the written consent and identification data and contacts were 
collected in this first contact. A 3-days food diary (FD) protocol was given to women, 
accompanied of the respective instructions for completing. FD should have been filled in the 3 
days previous to the following interview, scheduled for 15-16 gestational weeks, preferably in 
the same day of other appointments in Hospital. Women were instructed to attend fasting, in 
order to withdraw a blood sample. In the day previous to the start of FD (5 days before the 
interview), women received a phone call or a written message reminding the beginning of FD 
and the fasting condition in the interview day. 
The interview included these steps: blood sample collection (after that, a breakfast was 
provided); filling (by the interviewer) a structured questionnaire with demographic and lifestyle 
variables, past medical history, health status during pregnancy, and use of vitamin and mineral 
supplements (including details on type of supplementations, and timing of their initiation and 
cessation); application of a validated semi-quantitative FFQ to access diet; and collection of 
FD. 
 
Dietary and nutrient intake assessment 
In order to assess dietary intake, women answered to a semi-quantitative FFQ, applied by a 
trained interviewer and filled a 3-days FD. 
FFQ applied to access dietary intake comprise eighty-six food or food group items. Frequency 
of consumption was recorded into nine pre-specified categories from “never or less than once 
per month” to “six or more times per day”. Pre-specified portion sizes were allocated to each 
food item. Dietary intake was estimated by multiplying the frequency of intake for any given 
item by its respective portion size, in grams, and by a seasonal variation factor for foods 
consumed only in some seasons. The FFQ used had been validated to assess diet among 
Portuguese pregnant women(146). The FFQ reported usual diet during the first pregnancy 
trimester.  
To the fulfilment of a 3-days FD, a protocol was given to each woman, containing written 
instructions, an example of one day of record and a page with standardized measures, in order 
to facilitate the completion. The means nutrients intake of the three days were calculated.  
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The conversion of foods into nutrients was performed through the Food Processor Plus 
program, version SQL (ESHA Research, Salem, OR, USA). This database has been 
supplemented with nutritional composition of Portuguese foods and recipes, using data from 
Portuguese food composition tables(62, 151) and national(152-155) and international(156-
159) publications. 
 
Folate status assessment 
An overnight fasting blood sample was collected to determine a complete blood count (CBC), 
serum folate concentration, and erythrocyte folate concentration. Three tubes were collected: 
two EDTA (ethylenediaminetetraacetic acid) tubes, one for a complete blood test 
determination, and another for folate assessment in erythrocytes, and one gel tube was used 
for serum folate determination. Both tubes intended for folate assessments were protected 
with foil in order to protect from direct light exposure. The biochemical analysis of erythrocyte 
folate and serum folate were performed in the Abbott ARCHITECT® Folate based on a 
chemiluminescent microparticle immunoassay (CMIA) principle(160). For erythrocyte folate, 
the sample was firstly haemolysed with haemolysis reagent containing ascorbic acid and 
guanidine hydrochloride(160). 
 
Statistical analysis 
The Kolmogorov-Smirnov test was used to check normality of the variables distribution. 
Continuous variables were described as mean and standard deviation or as median and 
interquartile range (percentile 25; percentile 75), as adequate. Categorical variables were 
described as absolute and relative frequencies. 
Total duration of folic acid supplementation during pregnancy was multiplied by the quantity of 
folic acid provided and divided by the pregnancy duration until the evaluation day. Folic acid 
from supplements was further expressed as DFE: 1 μg of DFE = 1 μg of folate = 0.6 μg of folic 
acid from a supplement consumed with food(3). After that, final quantities were added to 
estimates of folate intake by diet in order to quantify total folate intake.  
Mean nutrients intake estimated by FFQ and by FD were compared using the paired-samples 
t-test. Total folate plus folic acid intake, considering both dietary methods and supplements, 
were compared by Wilcoxon test. 
Erythrocyte folate and serum folate concentrations were log-transformed in order to assume a 
normal distribution. Pearson correlation coefficients were computed to estimate the association 
between folate intake and folic acid supplementation and biomarkers.  
All statistical analyses were performed with the IBM SPSS Statistics for Windows, Version 21.0 
(Released 2012. Armonk, NY: IBM Corp.). 
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RESULTS 
Participant characteristics 
Among the participants, we analysed 84 subjects, corresponding to the information that was 
computerized. The characteristics of the analysed participants are shown in Table 1. Pregnant 
women had a mean age of 31.8±5.0 at entry into the study. A third had 9 or less completed 
years of schooling. Almost all (91.7%) were married or in fact union. About a quarter reported 
smoking in the 3 months before pregnancy, in a median of 9/day cigarettes (interquartile range: 
6-12). From the analysed participants, 23 (27.4%) were overweight and 13 (15.5%) were obese 
when got pregnant. It was the first delivery for about half (44.0%) of the women and gravidity 
ranged between 1 and 6 pregnancies (including actual). Three reported congenital anomalies 
in a previous pregnancy. Over half pregnancies were planned (66.7%) and the first prenatal 
visit occurred at 7.5±3.1 weeks of gestational age. It occurred before 6 gestational weeks for 
21(25.0%) women. Most pregnant women experienced nausea (72.6%) and/or vomiting 
(61.9%) in the first trimester of pregnancy.  
  
Table 1. Characteristics of the analysed participants (n=84). 
Characteristic Result 
Maternal age (years) [mean (SD)] 31.8 (5.0) 
Maternal education (years) [n (%)] 
     ≤ 9 years 
     10 – 12 years 
     > 12 years 
 
28 (33.3) 
33 (39.3) 
23 (27.4) 
Marital status [n (%)] 
     Married/ fact union 
     Other 
 
77 (91.7) 
7 (8.3) 
Maternal smoking habits 
     In the 3 months before pregnancy [n (%)] 
          No. cigarettes per day [median (P25; P75)] 
     During the first pregnancy trimester [n (%)] 
          No. cigarettes per day [median (P25; P75)] 
 
19 (22.6) 
8.0 (3.0; 20.0) 
14 (16.7) 
3.5 (1.6; 5.3) 
Pre-pregnancy BMI (kg/m2) [mean (SD)] 
     25.0-29.9 [n (%)] 
     ≥ 30.0 [n (%)] 
25.6 (5.7) 
23 (27.4)  
13 (15.5) 
Gravidity = 1 [n (%)] 37 (44.0) 
Pregnancy after assisted reproduction techniques [n (%)] 6 (7.1) 
Planned pregnancy [n (%)] 56 (66.7) 
Gestational age at first prenatal visit (weeks) [mean (SD)] 7.5 (3.1) 
Reported health problems in first trimester [n (%)] 
     Nausea 
     Vomiting 
     Diarrhea 
     Constipation 
     Urinary infection 
 
61 (72.6) 
52 (61.9) 
14 (16.7) 
24 (28.6) 
17 (20.2) 
SD: standard deviation. P25: percentile 25. P75: percentile 75. BMI: body mass index. No.: number.  
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Socio-demographic characteristics (maternal age and education, marital status, gravidity, 
pregnancy after assisted reproduction, planned pregnancy, and gestational age at first prenatal 
visit) were compared between women by had taken or not had taken folic acid supplements 
before pregnancy (results not shown). Women who had taken folic acid supplements before 
pregnancies were more likely to have planned pregnancies (94.3% vs.  46.9%; P < 0.001) and 
to have their first delivery (57.1% vs. 34.7%; P < 0.05) compared to unsupplemented women. 
Others characteristics had no statistical significant difference. The mean age was equal.  
 
Folic acid supplementation 
Prevalence of use of folic acid supplements during the three months before pregnancy was 
41.7%, increasing to 91.7% during the first pregnancy trimester, as can be seen from the Table 
2. The median dose of folic acid supplements used in the first trimester of pregnancy was 3.29 
mg (interquartile range: 1.85-5.00), corresponding to 5.58 mg expressed as DFE. 
Almost all (33/35) women who took any supplements in the three months before to get 
pregnant, took supplements containing 5 mg of folic acid per day. 
 
Table 2. Folic acid supplements use (n=84). 
Use of folic acid supplements Result 
During the 3 months before pregnancy [n (%)] 35 (41.7) 
During the first pregnancy trimester [n (%)]  77 (91.7) 
     Folic acid (mg) [median (P25; P75)]  
     Folic acid as DFE (mg) [median (P25; P75)] 
3.29 (1.85; 5.00) 
5.58 (3.15; 8.50) 
DFE: Dietary Folate Equivalents. 
 
Nutrient intake 
Absolute daily mean energy intake was 2410±534 kcal and 2042±508 kcal, accessed through 
FFQ and FD, respectively, as shown in Table 3. Energy, protein and carbohydrates obtained 
by FFQ and FD were significantly different (P < 0.05), but total fat and folate were not. Mean 
folate intake was 0.35±0.11 mg and 0.30±0.16 mg (by FFQ and FD, respectively).  Both values 
approximates the EAR for women (320 µg/day DFE), but were clearly below the EAR for 
pregnant women (520 µg/day DFE). According to the first cut-off point, the prevalence of folate 
inadequacy was 41.7% by FFQ. According to the second cut-off point, the prevalence of folate 
inadequacy was 95.2% using FFQ data and 91.7% using FD. 
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Table 3. Absolute daily energy, macronutrients and folate intakes, estimated by the food frequency 
questionnaire and food diaries, and folic acid supplementation, in the first trimester of pregnancy (n=84). 
Nutrient FFQ FD P 
 Mean (SD)  
Energy (kcal) 2410 (534) 2042 (508) 0.022 
Protein (g) 112.6 (23.1) 93.7 (24.1) 0.005 
Carbohydrates (g) 303.8 (82.5) 244.6 (69.4) 0.007 
Total fat (g) 86.7 (22.1) 78.3 (24.0) 0.209 
Folate (mg) 0.35 (0.11) 0.30 (0.16) 0.113 
 Median (P25; P75)  
Folate + folic acid as DFE (mg)  5.93 (3.46; 8.75) 5.95 (3.46; 8.71) 0.001 
FFQ: food frequency questionnaire. FD: food diary. DFE: Dietary Folate Equivalents.  
 
Folate plus folic acid median intake was nearby 6 mg DFE from both tools of dietary 
assessment, although the values were considered significantly different (P < 0.01).  
 
Folate status 
The results obtained from the preliminary analysis of biomarkers are presented in Table 4. 
The median and interquartile values for serum folate and erythrocyte folate were in the normal 
range, considering as folate deficiency values lower than 7 nmol/l for serum folate and lower 
than 300 nmol/l for erythrocyte folate(107). Only 4.8% of the analysed participants were 
classified as folate deficiency using the first criteria, but 13.1% considering the second criteria. 
All pregnant women with low serum folate levels had also low erythrocyte levels.  
 
Table 4. Folate status (n=84). 
Biochemical markers Median (P25; P75) 
Serum folate (nmol/l) 14.7 (13.0; 17.0) 
Erythrocyte folate (nmol/l) 476.2 (369.6; 660.9) 
Erythrocyte count* (106/l) 3.96 (3.76; 4.23) 
P25: percentile 25. P75: percentile 75. *RBC: Red blood cell count.  
 
Associations between nutrient intake and biomarkers 
From the analysed participants, were obtained the associations provided by Table 5. Folate 
intake (both by FFQ and FD) didn’t show any association with biomarkers, but folic acid alone 
or with folate intake showed.  
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Table 5. Associations between folate intake and folic acid supplementation and folate status (n=84). 
Nutrient Serum folate Erythrocyte folate 
 Pearson correlation coefficients 
Folate by FFQ -0.075 -0.147 
Folate by FD 0.098 0.084 
Folic acid as DFE 0.316** 0.251* 
Folate by FFQ + folic acid as DFE 0.312** 0.245* 
Folate by FD + folic acid as DFE 0.352** 0.263* 
FFQ: food frequency questionnaire. FD: food diary. DFE: Dietary Folate Equivalents. * P < 0.05; ** P < 0.01. 
 
 
 
DISCUSSION 
Maternal folate intake is clearly below the international recommendations during pregnancy. 
Considering the more robust biomarker for folate (erythrocyte levels), 13% of women showed 
low levels. Although supplementation prevalence was very high during pregnancy, the median 
age at initiation is visibly late, based on the knowledge that neural tube closure occurs about 
28 days after conception. More than 60% of pregnancies were planned, however 
preconception supplementation occurred in only about 40%. 
According to this study, being a planned pregnancy was the main determinant of using folic 
acid supplementation before pregnancy. This finding is consistent with a previous study(120).  
It is interesting to note that only 33.3% pregnancies were unplanned, below the estimated 41% 
worldwide(109) and the 43.4% from a Portuguese birth cohort (Geração XXI) nested study(13). 
The maternal education level seems similar to Portuguese population for this group(129), 
although with a slightly higher education level compared with the mentioned cohort.  Overall, 
the socio-demographic characteristics analysed had no clear relationship with the use of folic 
acid supplements. 
These differences in relation to others studies, could result from a possible selection bias, led 
by the fact that women were invited at first trimester ultrasound or in the prenatal visits 
(gestational age approximately of 12 weeks), where some women do not know yet they are 
pregnant, which could result in more than the previous obtained percentage of women taking 
folic acid supplements before pregnancy (41.7% against 18.6% in the referred cohort(13)). 
During pregnancy the prevalence of folic acid supplementation (91.7%) was, to some extent, 
similar to others studies (81.9%(120) and 96.8%(13)). The supplementation before pregnancy 
is consensually considered more effective than only in pregnancy, because most women know 
they are pregnant after the week 6 of pregnancy, when the neural tube closes.  
Another factor that could have risen the prevalence of folic acid supplementation is the high 
percentage of planned pregnancies. Concerning smoking habits, less (16.7%) than previous 
found (25% (13)) smoked in the first pregnancy trimester. This factor is associated with a lower 
folate intake (13), here not analysed. 
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Most pregnant women (61.9%) reported vomiting, which hypothetically could impair the intake 
of folate, although it does not modify the previous validation and reproducibility of the FQQ 
among Portuguese women (146). 
From the analysed participants, 23 (27.4%) were overweight, 13 (15.5%) were obese when 
got pregnant, and the mean body mass index was coincident with the cut-off point for 
overweigh. So it can be hypothesized that many of them have higher ingestion of calories than 
their need (from a Western dietary pattern and/or lower physical activity levels), and a lower 
ingestion of folate rich food (typical from a Western dietary pattern), which can explain the low 
level of folate intake. Obesity is considered a high risk factor for having low folate status.  
Almost all women that used supplements took the same dose: 5 mg of folic acid, which is 
internationally recommended only for high risk women. None had 400 µg of supplemented folic 
acid alone as, according to Infarmed (the national authority for drugs and health products), 
supplements of 400 µg of folic acid alone are not commercialized in Portugal, but only of 5 mg 
(126). 
Concerning folate intake, the mean of 350±110 µg/day and 300±160 µg/day (not significantly 
different in both FFQ and FD, respectively, being FFQ already validated for Portuguese 
pregnant women(146)) is consistent with previous findings that showed a mean intake of 300 
µg/day(13, 94). The median folate plus folic acid intake was nearby 6 mg DFE, greatly higher 
than the RDA for folate intake expressed in DFE plus supplementation of folic acid for 
prevention of NTD. Comparing to the best scenario: a high folate diet (600 µg/day) + folic acid 
intake (400 µg/day) = 600 µg DFE + (400 ÷ 0.6) µg DFE = 1270 µg DFE (approximately 1 mg 
DFE), the value of this sample is much higher (six-folder) than the “ideal” scenario. Here was 
considered the DRI values, but other recommendations from other entities could be 
considered. 
Even recommendations seems to be clearly satisfied considering supplementation and being 
supplementation prevalence quite high, a critical point remains, regarding the beginning of 
supplementation.  
Considering folate status, only 4.8% were inadequate in serum folate, and 13.3% in erythrocyte 
folate. The median values (P25; P75) were 14.7 (13.0; 17.0) nmol/l for serum folate and 476.2 
nmol/l (369.6; 660.9) for erythrocyte folate, all above the cut-off points considered. These high 
values can be mostly explained by the high supplementation in folic acid (5 mg), present in 
almost all women. Erythrocyte levels are considered a more robust biomarker, since it reflects 
the folate status approximately in the previous four months, in opposite to serum folate that 
reflects only the previous 3-4 days.  
Seeking the quantification of the association between folate and folic acid intakes and maternal 
folate levels, both intake sources were combined. However, we recognized that this 
combination could have some problems in the serum assays, regarding women that had 
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stopped supplementation more than week before the blood collection. It also important to 
emphasize that the physiological blood folate levels of pregnant women are not the same as 
non-pregnant women (usually lower) and this should be taken in consideration when analysing 
data(11). Considering the value of 13 nmol for serum folate, the median from this sample is 
above it. 
The results indicate that there is a modest association between folic acid supplementation and 
folate status, but failed to detect any association between folate intake and folate status in 
early pregnancy. One of the reasons for the weak moderate associations could be the 
supraphysiologic doses supplemented. Previous study referred the increase of unmetabolized 
folic acid when the doses are high.  
It is plausible that maternal folate levels are mainly justified by supplements intake. Considering 
that we selected the sample from an Obstetrics department, during the first pregnancy 
trimester, we have probably a biased image of the reality of Portuguese pregnant women, 
where the supplementation prevalence would be lower and in some cases initiated even later. 
The possibility to performed these blood assays around 4 th – 6th gestational weeks would be 
also interesting, in order to quantify the inadequacy in this crucial period. 
 
 
CONCLUSION 
Maternal folate intake is clearly below the international recommendations during pregnancy. 
Considering the respective biomarker (erythrocyte folate levels), 13% of women showed low 
levels. The study identified a moderate association between folic acid supplementation and 
folate status. It was shown a low intake of folate during pregnancy and a late initiation of the 
supplementation, indicating that guidelines are unlikely to be effective. Only being a planned 
pregnancy was the main determinant of starting folic acid supplementation in the 
preconception, as desirable. 
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GENERAL CONCLUSION 
 
Regardless the importance of adequate levels of folate during pregnancy, many countries has 
not clear recommendations regarding the possibilities for warrant this adequacy. 
Diet should be the first element considered, namely because a healthy diet should be 
encouraged independently of the pregnancy condition. Based on the literature review, the 
folate content of a prudent dietary pattern plan was almost double of a Western dietary pattern 
plan, and achieved the RDA for folate for women in childbearing age. Public health efforts 
should incorporate practical advice on storing and cooking and emphasize the importance of 
the prudent dietary pattern to increase folate intakes. 
Disparities in what concerns folate adequacy were seen among different countries. However, 
the recommendation of 400 µg of folic acid in the periconceptional period is predominant. In 
Portugal, a quantitative recommendation is not available. Only high levels supplements are 
commercialized, so the majority of women take this kind of supplements. High intakes of folic 
acid have being shown through pregnancy outcomes studies, both in mother and child, early 
and later in life, to have adverse effects. Accurate recommendations are needed in Portugal. 
Intake of folate in pregnant women was below the recommended level for pregnancy in 91.7% 
pregnant women. Although, the median folate plus folic acid intake was nearby 6 mg DFE, six-
folder higher than the recommendations for folate intake plus supplementation of folic acid for 
prevention of NTD. The folic acid intake alone was 12-folder higher, without distinction from 
high risk women, due to use of high doses of folic acid (5 mg) without differentiate low risk 
women. Concerning folate status, only 4.8% of the analysed participants were classified as 
folate deficiency using serum folate, but 13.1% through erythrocyte folate.  
The study identified a modest association positive association between folic acid 
supplementation and folate status, but not with folate intake and folate status. It was shown a 
low intake of folate during pregnancy and a late initiation of the supplementation, indicating 
that guidelines are unlikely to be effective. Only being a planned pregnancy was the main 
determinant of starting folic acid supplementation in the preconception, as desirable.  
In Portugal new guidelines are needed, including quantitative recommendations regarding folic 
acid supplementation and emphasizing a healthy dietary pattern. 
 
  
                                                                                                                           
55 
 
REFERENCES 
1. Prevention of neural tube defects: results of the Medical Research Council Vitamin 
Study. MRC Vitamin Study Research Group. Lancet. 1991;338(8760):131-7. 
2. Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by 
periconceptional vitamin supplementation. The New England journal of medicine. 
1992;327(26):1832-5. 
3. Institute of Medicine. Dietary Reference Intakes: The Essentia l Guide to Nutrient 
Requirements. Otten JJ, Hellwig JP, Meyers LD, editors. Washington, DC: The National 
Academies Press; 2006. 
4. Wilcox AJ, Lie RT, Solvoll K, Taylor J, McConnaughey DR, Abyholm F, et al. Folic acid 
supplements and risk of facial clefts: national population based case-control study. BMJ 
(Clinical research ed). 2007;334(7591):464. 
5. Kelly D, O'Dowd T, Reulbach U. Use of folic acid supplements and risk of cleft lip and 
palate in infants: a population-based cohort study. The British journal of general practice : the 
journal of the Royal College of General Practitioners. 2012;62(600):e466-72. 
6. De-Regil LM, Fernandez-Gaxiola AC, Dowswell T, Pena-Rosas JP. Effects and safety 
of periconceptional folate supplementation for preventing birth defects. The Cochrane 
database of systematic reviews. 2010(10):Cd007950. 
7. Rozendaal AM, van Essen AJ, Te Meerman GJ, Bakker MK, van der Biezen JJ, 
Goorhuis-Brouwer SM, et al. Periconceptional folic acid associated with an increased risk of 
oral clefts relative to non-folate related malformations in the Northern Netherlands: a 
population based case-control study. European journal of epidemiology. 2013. 
8. Institute of Medicine. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin 
B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. Washington,DC: National 
Academies Press; 1998. 
9. World Health Organization. WHO Guidelines Approved by the Guidelines Review 
Committee.  Guideline: Daily Iron and Folic Acid Supplementation in Pregnant Women. 
Geneva: World Health Organization; 2012. 
10. World Health Organization. Prevention of neural tube defects.  Standards for Maternal 
and Neonatal Care Department of Making Pregnancy Safer. Geneva: World Health 
Organization; 2006. 
11. Steegers-Theunissen RP, Twigt J, Pestinger V, Sinclair KD. The periconceptional 
period, reproduction and long-term health of offspring: the importance of one-carbon 
metabolism. Human reproduction update. 2013;19(6):640-55. 
12. Vandevijvere S, Amsalkhir S, Van Oyen H, Moreno-Reyes R. Determinants of folate 
status in pregnant women: results from a national cross-sectional survey in Belgium. European 
journal of clinical nutrition. 2012;66(10):1172-7. 
13. Pinto E, Barros H, dos Santos Silva I. Dietary intake and nutritional adequacy prior to 
conception and during pregnancy: a follow-up study in the north of Portugal. Public health 
nutrition. 2009;12(7):922-31. 
14. European Food Safety Authority. Folic acid: an update on scientific developments. 
Uppsala, Sweden: 2009. 
15. Huo Y, Qin X, Wang J, Sun N, Zeng Q, Xu X, et al. Efficacy of folic acid supplementation 
in stroke prevention: new insight from a meta-analysis. International journal of clinical practice. 
2012;66(6):544-51. 
16. Wang X, Qin X, Demirtas H, Li J, Mao G, Huo Y, et al. Eff icacy of folic acid 
supplementation in stroke prevention: a meta-analysis. Lancet. 2007;369(9576):1876-82. 
17. Butterworth CE, Jr., Tamura T. Folic acid safety and toxicity: a brief review. The 
American journal of clinical nutrition. 1989;50(2):353-8. 
18. United Nations. United Nations Statistics Division 2012 [2013-10]. Available from: 
http://unstats.un.org/unsd/methods/m49/m49regin.htm. 
                                                                                                                           
56 
 
19. EUROCAT. World map of countries having mandatory fortification of food with folic 
acid. 2013 [2013-09]. Available from: http://www.eurocat-network.eu/content/EUROCAT-Folic-
Acid-Map.pdf. 
20. Institute of Medicine. Chapter 4 - Dietary Reference Intakes for Thiamin, Riboflavin, 
Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. In: Suitor CW, 
Meyers LD, Food and Nutrition Board, editors. Dietary Reference Intakes Research Synthesis 
Workshop Summary. Washington, DC: The National Academies Press; 2006. 
21. U.S. Department of Agriculture, U.S. Department of Health and Human Services. 
Dietary Guidelines for Americans. 7th ed. Washington, DC: U.S. Government Printing Office; 
2010. 
22. Food and Agriculture Organization of the United Nations, World Health Organization. 
FAO/WHO Expert Consultation on Human Vitamin and Mineral Requirements. FAO/WHO, 
editor. Bangkok, Thailand2001. 
23. Cole BF, Baron JA, Sandler RS, Haile RW, Ahnen DJ, Bresalier RS, et al. Folic acid for 
the prevention of colorectal adenomas: a randomized clinical trial. JAMA : the journal of the 
American Medical Association. 2007;297(21):2351-9. 
24. Ebbing M, Bonaa KH, Nygard O, Arnesen E, Ueland PM, Nordrehaug JE, et al. Cancer 
incidence and mortality after treatment with folic acid and vitamin B12. JAMA : the journal of 
the American Medical Association. 2009;302(19):2119-26. 
25. Kennedy DA, Stern SJ, Moretti M, Matok I, Sarkar M, Nickel C, et al. Folate intake and 
the risk of colorectal cancer: a systematic review and meta-analysis. Cancer epidemiology. 
2011;35(1):2-10. 
26. Vollset SE, Clarke R, Lewington S, Ebbing M, Halsey J, Lonn E, et al. Effects of folic 
acid supplementation on overall and site-specific cancer incidence during the randomised 
trials: meta-analyses of data on 50,000 individuals. Lancet. 2013;381(9871):1029-36. 
27. Troen AM, Mitchell B, Sorensen B, Wener MH, Johnston A, Wood B, et al. 
Unmetabolized folic acid in plasma is associated with reduced natural killer cell cytotoxicity 
among postmenopausal women. The Journal of nutrition. 2006;136(1):189-94. 
28. Kelly P, McPartlin J, Goggins M, Weir DG, Scott JM. Unmetabolized folic acid in serum: 
acute studies in subjects consuming fortified food and supplements. The American journal of 
clinical nutrition. 1997;65(6):1790-5. 
29. Scientific Committee on Food. Opinion of the Scientific Committee on Food on the 
Tolerable Upper Intake Level of Folate. In: European Commission, editor. Brussels: European 
Comission; 2000. 
30. Sweeney MR, McPartlin J, Scott J. Folic acid fortification and public health: report on 
threshold doses above which unmetabolised folic acid appear in serum. BMC public health. 
2007;7:41. 
31. Tam C, O'Connor D, Koren G. Circulating unmetabolized folic Acid: relationship to 
folate status and effect of supplementation. Obstetrics and gynecology international. 
2012;2012:485179. 
32. Bailey RL, Mills JL, Yetley EA, Gahche JJ, Pfeiffer CM, Dwyer JT, et al. Unmetabolized 
serum folic acid and its relation to folic acid intake from diet and supplements in a nationally 
representative sample of adults aged > or =60 y in the United States. The American journal of 
clinical nutrition. 2010;92(2):383-9. 
33. Crider KS, Bailey LB, Berry RJ. Folic acid food fortification-its history, effect, concerns, 
and future directions. Nutrients. 2011;3(3):370-84. 
34. Kim YI. Will mandatory folic acid fortification prevent or promote cancer? The American 
journal of clinical nutrition. 2004;80(5):1123-8. 
35. Achon M, Reyes L, Alonso-Aperte E, Ubeda N, Varela-Moreiras G. High dietary folate 
supplementation affects gestational development and dietary protein utilization in rats. The 
Journal of nutrition. 1999;129(6):1204-8. 
36. Cooney CA, Dave AA, Wolff GL. Maternal methyl supplements in mice affect epigenetic 
variation and DNA methylation of offspring. The Journal of nutrition. 2002;132(8 Suppl):2393s-
400s. 
                                                                                                                           
57 
 
37. Ulrich CM, Potter JD. Folate supplementation: too much of a good thing? Cancer 
epidemiology, biomarkers & prevention : a publication of the American Association for Cancer 
Research, cosponsored by the American Society of Preventive Oncology. 2006;15(2):189-93. 
38. Wien TN, Pike E, Wisloff T, Staff A, Smeland S, Klemp M. Cancer risk with folic acid 
supplements: a systematic review and meta-analysis. BMJ open. 2012;2(1):e000653. 
39. Qin X, Cui Y, Shen L, Sun N, Zhang Y, Li J, et al. Folic acid supplementation and cancer 
risk: a meta-analysis of randomized controlled trials. International journal of cancer Journal 
international du cancer. 2013;133(5):1033-41. 
40. Stolzenberg-Solomon RZ, Chang SC, Leitzmann MF, Johnson KA, Johnson C, Buys 
SS, et al. Folate intake, alcohol use, and postmenopausal breast cancer risk in the Prostate, 
Lung, Colorectal, and Ovarian Cancer Screening Trial. The American journal of  clinical 
nutrition. 2006;83(4):895-904. 
41. World Cancer Research Fund, American Institute for Cancer Research. Food, Nutrition, 
Physical Activity, and the Prevention of Cancer: a Global Perspective. Washington, DC: AICR; 
2007. 
42. National Center for Biotechnology Information. MeSH - Pregnancy Outcome.  USA: 
U.S. National Library of Medicine; 2013 [2013-10]. Available from: 
http://www.ncbi.nlm.nih.gov/mesh/?term=pregnancy+outcomes. 
43. Charles DH, Ness AR, Campbell D, Smith GD, Whitley E, Hall MH. Folic acid 
supplements in pregnancy and birth outcome: re-analysis of a large randomised controlled trial 
and update of Cochrane review. Paediatric and perinatal epidemiology. 2005;19(2):112-24. 
44. de Benoist B. Conclusions of a WHO Technical Consultation on folate and vitamin B12 
deficiencies. Food and nutrition bulletin. 2008;29(2 Suppl):S238-44. 
45. Fekete K, Berti C, Trovato M, Lohner S, Dullemeijer C, Souverein OW, et al. Effect of 
folate intake on health outcomes in pregnancy: a systematic review and meta-analysis on birth 
weight, placental weight and length of gestation. Nutrition journal. 2012;11:75. 
46. Lassi ZS, Salam RA, Haider BA, Bhutta ZA. Folic acid supplementation during 
pregnancy for maternal health and pregnancy outcomes. The Cochrane database of 
systematic reviews. 2013;3:Cd006896. 
47. Yajnik CS, Deshpande SS, Jackson AA, Refsum H, Rao S, Fisher DJ, et al. Vitamin 
B12 and folate concentrations during pregnancy and insulin resistance in the offspring: the 
Pune Maternal Nutrition Study. Diabetologia. 2008;51(1):29-38. 
48. Burdge GC, Lillycrop KA. Folic acid supplementation in pregnancy: Are there devils in 
the detail? The British journal of nutrition. 2012;108(11):1924-30. 
49. Whitrow MJ, Moore VM, Rumbold AR, Davies MJ. Effect of supplemental folic acid in 
pregnancy on childhood asthma: a prospective birth cohort study. American journal of 
epidemiology. 2009;170(12):1486-93. 
50. Keating E. Suplementação com ácido fólico: impacto metabólico transgeracional. 
FMUP, 2013. 
51. Torrens C, Brawley L, Anthony FW, Dance CS, Dunn R, Jackson AA, et al. Folate 
supplementation during pregnancy improves offspring cardiovascular dysfunction induced by 
protein restriction. Hypertension. 2006;47(5):982-7. 
52. Herrmann W, Obeid R. The mandatory fortification of staple foods with folic acid: a 
current controversy in Germany. Deutsches Arzteblatt international. 2011;108(15):249-54. 
53. Kappen C. Modeling anterior development in mice: Diet as modulator of risk for neural 
tube defects. American journal of medical genetics Part C, Seminars in medical genetics. 
2013;163(4):333-56. 
54. Crider KS, Cordero AM, Qi YP, Mulinare J, Dowling NF, Berry RJ. Prenatal folic acid 
and risk of asthma in children: a systematic review and meta-analysis. The American journal 
of clinical nutrition. 2013;98(5):1272-81. 
55. Haberg SE, London SJ, Stigum H, Nafstad P, Nystad W. Folic acid supplements in 
pregnancy and early childhood respiratory health. Archives of disease in childhood. 
2009;94(3):180-4. 
                                                                                                                           
58 
 
56. Haberg SE, London SJ, Nafstad P, Nilsen RM, Ueland PM, Vollset SE, et al. Maternal 
folate levels in pregnancy and asthma in children at age 3 years. The Journal of allergy and 
clinical immunology. 2011;127(1):262-4, 4.e1. 
57. Sengpiel V, Bacelis J, Myhre R, Myking S, Pay AD, Haugen M, et al. Folic acid 
supplementation, dietary folate intake during pregnancy and risk for spontaneous preterm 
delivery: a prospective observational cohort study. BMC pregnancy and childbirth. 
2013;13:160. 
58. Steegers-Theunissen RP, Obermann-Borst SA, Kremer D, Lindemans J, Siebel C, 
Steegers EA, et al. Periconceptional maternal folic acid use of 400 microg per day is related 
to increased methylation of the IGF2 gene in the very young child. PloS one. 2009;4(11):e7845. 
59. Haggarty P, Hoad G, Campbell DM, Horgan GW, Piyathilake C, McNeill G. Folate in 
pregnancy and imprinted gene and repeat element methylation in the offspring. The American 
journal of clinical nutrition. 2013;97(1):94-9. 
60. Harper D. Online Etymology Dictionary 2013 [cited 2013-06]. Available from: 
http://www.etymonline.com/index.php?allowed_in_frame=0&search=folic&searchmode=none
. 
61. Mahan LK, Escott-Stump S. Krause's Food and Nutrition Therapy. 12 ed. Canada: 
Saunders; 2008. 
62. Martins I, Porto A, Oliveira L. Tabela da Composição de Alimentos. Lisboa: Instituto 
Nacional de Saúde Dr. Ricardo Jorge; 2006. 
63. U.S. Department of Agriculture. National Nutrient Database for Standard Reference: 
USDA; 2011 [2013-06]. Available from: http://ndb.nal.usda.gov/. 
64. Gregory JF, 3rd. Case study: folate bioavailability. The Journal of nutrition. 2001;131(4 
Suppl):1376s-82s. 
65. McKillop DJ, Pentieva K, Daly D, McPartlin JM, Hughes J, Strain JJ, et al. The effect of 
different cooking methods on folate retention in various foods that are amongst the major 
contributors to folate intake in the UK diet. The British journal of nutrition. 2002;88(6):681-8. 
66. Witthoft CM, Forsskn K, Johannesson L, Jagerstad M. Folates - food sources, 
analyses, retention and bioavailability. Scandinavian Journal of Nutrition. 1999;43:138-46. 
67. Malin J. Total folate activity in Brussel sprouts: the effects of storage, processing, 
cooking and ascorbic content. Journal of Food Technology. 1977;12:623–32. 
68. Dang J, Arcot J, Shrestha A. Folate retention in selected processed legumes. Food 
chemistry. 2000;68(3):295-8. 
69. Leichter J, Switzer V, Landymore A. Effect of cooking on folate content of vegetables 
Nutrition Reports International. 1978;18:475–9. 
70. Czarnowska M, Gujska E. Effect of freezing technology and storage conditions on 
folate content in selected vegetables. Plant foods for human nutrition (Dordrecht, Netherlands). 
2012;67(4):401-6. 
71. Rodrigues SS, Franchini B, Graca P, de Almeida MD. A new food guide for the 
Portuguese population: development and technical considerations. Journal of nutrition 
education and behavior. 2006;38(3):189-95. 
72. Sotres-Alvarez D, Siega-Riz AM, Herring AH, Carmichael SL, Feldkamp ML, Hobbs 
CA, et al. Maternal dietary patterns are associated with risk of neural tube and congenital heart 
defects. American journal of epidemiology. 2013;177(11):1279-88. 
73. Instituto Nacional de Estatística. Balança Alimentar Portuguesa 2003-2008. INE, 2010 
[2013-06]. Available from: 
http://www.ine.pt/xportal/xmain?xpid=INE&xpgid=ine_destaques&DESTAQUESdest_boui=8
3386467&DESTAQUESmodo=2&xlang=pt. 
74. Murphy EW, Criner PE, Gray BC. Comparisons of methods for calculating retention of 
nutrients in cooked foods. Journal of agricultural and food chemistry. 1975;23(6):1153-7. 
75. U.S. Department of Agriculture. USDA Table of Nutrient Retention Factors Release 6. 
Maryland, 2007 [2013-08]. Available from: 
http://www.ars.usda.gov/SP2UserFiles/Place/12354500/Data/retn/retn06.pdf. 
76. Centers for Disease Control and Prevention. Use of Supplements Containing Folic Acid 
Among Women of Childbearing Age - United States, 2007. In: Morbidity and Mortality Weekly 
                                                                                                                           
59 
 
Report. Atlanta: CDC; 2008 [2013-09]. Available from: 
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5701a3.htm. 
77. Kawashima A, Madarame T, Koike H, Komatsu Y, Wise JA. Four week 
supplementation with mixed fruit and vegetable juice concentrates increased protective serum 
antioxidants and folate and decreased plasma homocysteine in Japanese subjects. Asia 
Pacific journal of clinical nutrition. 2007;16(3):411-21. 
78. Food and Agriculture Organization of the United Nations, World Health Organization. 
Vitamin and mineral requirements in human nutrition. 2 ed. China: 2004. 
79. Brouwer IA, van Dusseldorp M, West CE, Meyboom S, Thomas CM, Duran M, et al. 
Dietary folate from vegetables and citrus fruit decreases plasma homocysteine concentrations 
in humans in a dietary controlled trial. The Journal of nutrition. 1999;129(6):1135-9. 
80. Machado A, Feijóo M. Ácido fólico e anomalias congénitas: conhecimentos da 
população portuguesa. Rev Port Clin Geral. 2006;22:149-60. 
81. Tamura T, Stokstad EL. The availability of food folate in man. British journal of 
haematology. 1973;25(4):513-32. 
82. Hytten FE. The renal excretion of nutrients in pregnancy. Postgraduate medical journal. 
1973;49(575):625-9. 
83. Pei L, Zhu H, Ren A, Li Z, Hao L, Finnell RH, et al. Reduced folate carrier gene is a risk 
factor for neural tube defects in a Chinese population. Birth defects research Part A, Clinical 
and molecular teratology. 2005;73(6):430-3. 
84. Mayes P. Struture and function of the water-soluble vitamins. In: Murray R, Granner D, 
Mayes P, Rodwell V, editors. Harper’s Biochemistry. Stamford: Appleton & Lange; 2000. p. 
627-41. 
85. Beckmann C, Ling F, Barzansky B, Herbert W, Laube D, Smith R. Obstetrics and 
Gynecology. 6 ed. China: Lippincott Williams & Wilkins; 2010. 
86. Escott-Stump S. Nutrição relacionada ao diagnóstico e tratamento. 5 ed. Barueri: 
Manole; 2007. 
87. World Health Organization. Serum and red blood cell folate concentrations for 
assessing folate status in populations. Vitamin and Mineral Nutrition Information System. 
Geneva: WHO, 2012. 
88. Tamura T, Picciano MF. Folate and human reproduction. The American journal of 
clinical nutrition. 2006;83(5):993-1016. 
89. Farrell CJ, Kirsch SH, Herrmann M. Red cell or serum folate: what to do in clinical 
practice? Clinical chemistry and laboratory medicine : CCLM / FESCC. 2013;51(3):555-69. 
90. Ihara H, Watanabe T, Aoki Y, Nagamura Y, Totani M, Hashizume N. Dietary folate 
intake and serum folate status in Japanese women of childbearing age. Journal of Analytical 
Bio-Science. 2009;32(2). 
91. Berti C, Fekete K, Dullemeijer C, Trovato M, Souverein OW, Cavelaars A, et al. Folate 
intake and markers of folate status in women of reproductive age, pregnant and lactating 
women: a meta-analysis. Journal of nutrition and metabolism. 2012;2012:470656. 
92. Scientific Committee on Food. Report of the Scientific Committee on Food. Nutrition 
and energy intakes for the European Community. Commission of the European Communities; 
1993. 
. 
93. de Bree A, van Dusseldorp M, Brouwer IA, van het Hof KH, Steegers-Theunissen RP. 
Folate intake in Europe: recommended, actual and desired intake. European journal of clinical 
nutrition. 1997;51(10):643-60. 
94. European Nutrition and Health Report 2009. Vienna: European Union, 2009. 
95. Sieber R, Eyer H. Nährstoffzufuhr: Neue Referenzwerte - Chance für Landwirtschaft. 
Agrarforschung. 2001;8(2):72-7. 
96. Becker W, Lyhne N, Pedersen A, Aro A, Fogelholm M, Þhórsdottir I, et al. Nordic 
Nutrition Recommendations 2004 - integrating nutrition and physical activity. Scandinavian 
Journal of Nutrition. 2004;48(4):178-87. 
97. Direcção-Geral da Saúde. Portugal - Alimentação Saudável em Números - 2013. 
Lisboa: 2013. 
                                                                                                                           
60 
 
98. Tabacchi G, Wijnhoven TM, Branca F, Roman-Vinas B, Ribas-Barba L, Ngo J, et al. 
How is the adequacy of micronutrient intake assessed across Europe? A systematic literature 
review. The British journal of nutrition. 2009;101 Suppl 2:S29-36. 
99. Ray JG, Meier C, Vermeulen MJ, Wyatt PR, Cole DE. Association between folic acid 
food fortification and congenital orofacial clefts. The Journal of pediatrics. 2003;143(6):805-7. 
100. Vujkovic M, Ocke MC, van der Spek PJ, Yazdanpanah N, Steegers EA, Steegers-
Theunissen RP. Maternal Western dietary patterns and the risk of developing a cleft lip with or 
without a cleft palate. Obstetrics and gynecology. 2007;110(2 Pt 1):378-84. 
101. Krapels IP, van Rooij IA, Ocke MC, West CE, van der Horst CM, Steegers-Theunissen 
RP. Maternal nutritional status and the risk for orofacial cleft offspring in humans. The Journal 
of nutrition. 2004;134(11):3106-13. 
102. Rosano A, Botto LD, Botting B, Mastroiacovo P. Infant mortality and congenital 
anomalies from 1950 to 1994: an international perspective. Journal of epidemiology and 
community health. 2000;54(9):660-6. 
103. Kondo A, Kamihira O, Ozawa H. Neural tube defects: prevalence, etiology and 
prevention. International journal of urology : official journal of the Japanese Urological 
Association. 2009;16(1):49-57. 
104. Shurtleff DB. Epidemiology of neural tube defects and folic acid. Cerebrospinal fluid 
research. 2004;1(1):5. 
105. Morris JK, Wald NJ. Quantifying the decline in the birth prevalence of neural tube 
defects in England and Wales. Journal of medical screening. 1999;6(4):182-5. 
106. Sumiyoshi Y. How do we react on folic acid deficiency? Brain Spinal Cord 2007;14:1-
3. 
107. Bailey LB. New standard for dietary folate intake in pregnant women. The American 
journal of clinical nutrition. 2000;71(5 Suppl):1304s-7s. 
108. Botto LD, Lisi A, Robert-Gnansia E, Erickson JD, Vollset SE, Mastroiacovo P, et al. 
International retrospective cohort study of neural tube defects in relation to folic acid 
recommendations: are the recommendations working? BMJ (Clinical research ed). 
2005;330(7491):571. 
109. Singh S, Sedgh G, Hussain R. Unintended pregnancy: worldwide levels, trends, and 
outcomes. Studies in family planning. 2010;41(4):241-50. 
110. Brown RD, Langshaw MR, Uhr EJ, Gibson JN, Joshua DE. The impact of mandatory 
fortification of flour with folic acid on the blood folate levels of an Australian population. The 
Medical journal of Australia. 2011;194(2):65-7. 
111. Williams LJ, Rasmussen SA, Flores A, Kirby RS, Edmonds LD. Decline in the 
prevalence of spina bifida and anencephaly by race/ethnicity: 1995-2002. Pediatrics. 
2005;116(3):580-6. 
112. De Wals P, Tairou F, Van Allen MI, Uh SH, Lowry RB, Sibbald B, et al. Reduction in 
neural-tube defects after folic acid fortification in Canada. The New England journal of 
medicine. 2007;357(2):135-42. 
113. Lucock M, Yates Z. Folic acid fortification: a double-edged sword. Current opinion in 
clinical nutrition and metabolic care. 2009;12(6):555-64. 
114. Osterhues A, Ali NS, Michels KB. The role of folic acid fortification in neural tube 
defects: a review. Critical reviews in food science and nutrition. 2013;53(11):1180-90. 
115. Heseker HB, Mason JB, Selhub J, Rosenberg IH, Jacques PF. Not all cases of neural-
tube defect can be prevented by increasing the intake of folic acid. The British journal of 
nutrition. 2009;102(2):173-80. 
116. Stoll C, Alembik Y, Dott B. Are the recommendations on the prevention of neural tube 
defects working? European journal of medical genetics. 2006;49(6):461-5. 
117. Kennedy D, Koren G. Identifying women who might benefit from higher doses of folic 
acid in pregnancy. Canadian family physician Medecin de famille canadien. 2012;58(4):394-7. 
118. Talaulikar VS, Arulkumaran S. Folic acid in obstetric practice: a review. Obstetrical & 
gynecological survey. 2011;66(4):240-7. 
                                                                                                                           
61 
 
119. Bitzer J, von Stenglin A, Bannemerschult R. Women's awareness and periconceptional 
use of folic acid: data from a large European survey. International journal of women's health. 
2013;5:201-13. 
120. Lunet N, Rodrigues T, Correia S, Barros H. Adequacy of prenatal care as a major 
determinant of folic acid, iron, and vitamin intake during pregnancy. Cadernos de saude 
publica. 2008;24(5):1151-7. 
121. Braz P, Dias C. Report on Periconceptional Folic Acid Supplementation for Portugal. 
Folic Acid Special Reports - Survey of Folic Acid Policy and Practice in European Countries 
[Internet]. 2007; (2013-09). Available from: http://www.eurocat-
network.eu/preventionandriskfactors/folicacid/folicacidspecialreports. 
122. European Comission. Trustworthy websites on “Population groups" Brussels: 
European Comission; 2013 [2013-10]. Available from: 
http://ec.europa.eu/health/population_groups/portal/index_en.htm#tab_my_country. 
123. Theodosiou L, Green J. Emerging challenges in using health information from the 
internet. Advances in Psychiatric Treatment. 2003;9:387–96. 
124. Mo P. The Use of Internet for Health Education. J Biosafety Health Educ. 
2012;1(1):e102. 
125. Houston TK, Allison JJ. Users of Internet health information: differences by health 
status. Journal of medical Internet research. 2002;4(2):E7. 
126. Infarmed - Autoridade Nacional do Medicamento e Produtos de Saúde IP. Infomed - 
Base de dados de medicamentos: Ministério da Saúde; 2013. 
127. Infarmed - Autoridade Nacional do Medicamento e Produtos de Saúde IP. Consumos 
de Substâncias Ativas a Conter Ácido Fólico, no Âmbito do Serviço Nacional de Saúde, em 
Ambulatório. 2013. 
128. Eurostat. Eurostat - Tables, Graphs and Maps Interface (TGM) 2013 [2013-10]. 
Available from: 
http://epp.eurostat.ec.europa.eu/tgm/printTable.do?tab=table&plugin=1&language=en&pcod
e=tps00001&printPreview=true. 
129. Instituto Nacional de Estatística. Instituto Nacional de Estatística - Statistics Portugal 
2013 [2013-10]. Available from: http://www.ine.pt/. 
130. Instituto Nacional de Saúde Dr. Ricardo Jorge. Registo Nacional de Anomalias 
Congénitas (RENAC). Relatório de 2002-2007. Lisboa: 2010. 
131. Direcção-Geral da Saúde. Circular Normativa - Prestação de cuidados pré-
concepcionais - N.º2/DSMIA, 18-03-1998. In: Divisão de Saúde Materna Infantil e dos 
Adolescentes, editor.: Direcção-Geral da Saúde; 1998. 
132. Kaiser LL, Allen L. Position of the American Dietetic Association: nutrition and lifestyle 
for a healthy pregnancy outcome. Journal of the American Dietetic Association. 
2002;102(10):1479-90. 
133. Shah D, Sachdev HP. Maternal micronutrients and fetal outcome. Indian journal of 
pediatrics. 2004;71(11):985-90. 
134. Safi J, Joyeux L, Chalouhi GE. Periconceptional folate deficiency and implications in 
neural tube defects. Journal of pregnancy. 2012;2012:295083. 
135. Hall J, Solehdin F. Folic acid for the prevention of congenital anomalies. European 
journal of pediatrics. 1998;157(6):445-50. 
136. Kaiser L, Allen LH. Position of the American Dietetic Association: nutrition and lifestyle 
for a healthy pregnancy outcome. Journal of the American Dietetic Association. 
2008;108(3):553-61. 
137. Aranceta J, Serra-Majem L, Perez-Rodrigo C, Llopis J, Mataix J, Ribas L, et al. Vitamins 
in Spanish food patterns: the eVe Study. Public health nutrition. 2001;4(6a):1317-23. 
138. Bacardi-Gascon M, Ley y de Gongora S, Castro-Vazquez BY, Jimenez-Cruz A. 
Validation of a semiquantitative food frequency questionnaire to assess folate status. Results 
discriminate a high-risk group of women residing on the Mexico-US border. Archives of medical 
research. 2003;34(4):325-30. 
139. Cade J, Thompson R, Burley V, Warm D. Development, validation and utilisation of 
food-frequency questionnaires - a review. Public health nutrition. 2002;5(4):567-87. 
                                                                                                                           
62 
 
140. Ishihara J, Yamamoto S, Iso H, Inoue M, Tsugane S. Validity of a self-administered 
food frequency questionnaire (FFQ) and its generalizability to the estimation of dietary folate 
intake in Japan. Nutrition journal. 2005;4:26. 
141. Jackson MD, Walker SP, Younger NM, Bennett FI. Use of a food frequency 
questionnaire to assess diets of Jamaican adults: validation and correlation with biomarkers. 
Nutrition journal. 2011;10:28. 
142. Johansson I, Van Guelpen B, Hultdin J, Johansson M, Hallmans G, Stattin P. Validity 
of food frequency questionnaire estimated intakes of folate and other B vitamins in a region 
without folic acid fortification. European journal of clinical nutrition. 2010;64(8):905-13. 
143. Pufulete M, Emery PW, Nelson M, Sanders TA. Validation of a short food frequency 
questionnaire to assess folate intake. The British journal of nutrition. 2002;87(4):383-90. 
144. Verkleij-Hagoort AC, de Vries JH, Stegers MP, Lindemans J, Ursem NT, Steegers-
Theunissen RP. Validation of the assessment of folate and vitamin B12 intake in women of 
reproductive age: the method of triads. European journal of clinical nutrition. 2007;61(5):610-
5. 
145. Willett WC, Sampson L, Stampfer MJ, Rosner B, Bain C, Witschi J, et al. Reproducibility 
and validity of a semiquantitative food frequency questionnaire. American journal of 
epidemiology. 1985;122(1):51-65. 
146. Pinto E, Severo M, Correia S, dos Santos Silva I, Lopes C, Barros H. Validity and 
reproducibility of a semi-quantitative food frequency questionnaire for use among Portuguese 
pregnant women. Maternal & child nutrition. 2010;6(2):105-19. 
147. Kaaks RJ. Biochemical markers as additional measurements in studies of the accuracy 
of dietary questionnaire measurements: conceptual issues. The American journal of clinical 
nutrition. 1997;65(4 Suppl):1232s-9s. 
148. Willett W, Lenart E. Reproducibility and Validity of Food-Frequency Questionnaires.  
Nutritional Epidemiology. 2 ed. New York, 1998. 
149. Caudill MA, Cruz AC, Gregory JF, 3rd, Hutson AD, Bailey LB. Folate status response 
to controlled folate intake in pregnant women. The Journal of nutrition. 1997;127(12):2363-70. 
150. West AA, Yan J, Perry CA, Jiang X, Malysheva OV, Caudill MA. Folate-status response 
to a controlled folate intake in nonpregnant, pregnant, and lactating women. The American 
journal of clinical nutrition. 2012;96(4):789-800. 
151. Ferreira F, Graça M. Tabela de composição de alimentos portugueses. 2 ed. Lisboa: 
Instituto Nacional de Saúde Dr. Ricardo Jorge; 1985. 
152. Amaral C, Sequeira C. Iogurte – composição e valor nutritivo de variedades 
comercializadas em Portugal. Subsídio para a tabela de composição dos alimentos 
portugueses. Rev Port Nutr. 1993(3):35–52. 
153. Batista I, Bandarra N. Influência de quatro métodos culinários na composição química 
de várias espécies de peixe. Rev Port Nutr. 1993(3):5-14. 
154. Mano M, Meister M, Fontes M, Lobo P. Composição de alguns alimentos cozinhados. 
Alguns produtos servidos em ‘snack-bares’. Rev Port Nutr. 1989(4):19–24. 
155. Mano M, Meister M, Fontes M, Lobo P. Composição de sobremesas doces. Rev Port 
Nutr. 1989(1):16-24. 
156. Aro A, Amaral E, Kesteloot H, Rimestad A, Thamm M, van Poppel G. Trans fatty acids 
in French fries, soups, and snacks from 14 European countries: the TRANSFAIR study. J Food 
Compost Anal. 1998(11):170–7. 
157. Aro A, Antoine J, Pizzoferrato L, Reykdal O, Van Poppel G. Trans fatty acids in dairy 
and meat products from 14 European countries: the TRANSFAIR study. J Food Compos Anal 
1998(11):150–60. 
158. Aro A, Van Amelsvoort J, Becker W, Van Erp-baart M, Kafatos A, Leth T, et al. Trans 
fatty acids in dietary fats and oils from 14 European countries: the TRANSFAIR study. J Food 
Compost Anal. 1998(11):137–49. 
159. Van Erp-baart M, Couet C, Cuadrado C, Kafatos A, Stanley J, van Poppel G. Trans 
fatty acids in bakery products from 14 European countries: the TRANSFAIR study. J Food 
Compost Anal. 1998(11):161–9. 
160. Abbott. ARCHITECT System Folate. PT Folate REF 1P74: Abbott.; 2010. 
                                                                                                                           
63 
 
 
APPENDIX 
 
Appendix table of contents 
 
Appendix 1. Declaration of the Observational Internship in Hospital S. João – Porto 64 
Appendix 2. Declaration of the Observational Internship in USF +Carandá – Braga 65 
Appendix 3. Web addresses from official health organizations websites (Chapter 1) 66 
 
 
  
                                                                                                                           
64 
 
APPENDIX 1. DECLARATION OF THE OBSERVATIONAL INTERNSHIP IN HOSPITAL S. JOÃO – PORTO 
 
  
                                                                                                                           
65 
 
APPENDIX 2. DECLARATION OF THE OBSERVATIONAL INTERNSHIP IN USF +CARANDÁ – BRAGA 
 
 
  
                                                                                                                           
66 
 
APPENDIX 3. WEB ADDRESSES FROM OFFICIAL HEALTH ORGANIZATIONS WEBSITES (CHAPTER 1) 
 
Table a1. Web addresses and links from official health organizations websites of 46 countries worldwide 
and from World Health Organization. 
Country/ 
Entity 
Website Web address 
Australia National Health and Medical Research 
Council 
http://www.nhmrc.gov.au/_files_nhmrc/publications/attachments/n55_australian_dietary_guidelines_0.pdf a 
http://www.nhmrc.gov.au/_files_nhmrc/publications/attachments/n35.pdf a 
Food Standards Australia New 
Zealand 
http://www.foodstandard s.gov.au/consumer/generalissue s/pregnancy/folic/Pages/default.aspx 
b 
Austria Federal Ministry of Health – Public 
health portal 
https://www.ge sundheit.gv.at/Portal.Node/ghp/public/content/Ernaehrung_SchwangerschaftLN.html  b 
https://www.ge sundheit.gv.at/Portal.Node/ghp/public/content/Folsaeure_Folat_KH.html
 b 
Belgium – 
Flanders 
Flemish government – 
Child and Family 
Support Centre for Policy Research – 
Welfare, Health and Family 
http://www.kindengezin.be/zwangerschap-en-geboorte/zwanger/voeding/foliumzuur/ 
b 
 
http://www.kindengezin.be/img/foliumzuursuppletie.pdf 
a
 
Brazil Ministry of Health http://www2.ghc.com.br/GepNet/publicacoes/atencaosaudedagestante.pdf a 
http://189.28.128.100/dab/docs/publicacoes/geral/caderno_atencao_pre_natal_baixo_risco.pdf a 
Bulgaria The official Bulgarian patient 
organization Zachatie/ Conception 
Bulgarian portal 
http://www.zachatie.org/index.php?option=com_content&view=article&id=498:folacid ----&catid=164:---sp -
429&Itemid=135&highlight=WyJcdTA0NDRcdTA0M2VcdTA0M2JcdTA0MzhcdTA0MzVcdTA0MzJcdTA0MzAi
LCJcdTA0M2FcdTA0MzhcdTA0NDFcdTA0MzVcdTA0M2JcdTA0MzhcdTA0M2RcdTA0MzAiLCJcdTA0NDRcd
TA0M2VcdTA0M2JcdTA0MzhcdTA0MzVcdTA0MzJcdTA0MzAgXHUwNDNhXHUwNDM4XHUwNDQxXHUwN
DM1XHUwNDNiXHUwNDM4XHUwNDNkXHUwNDM wIl0=
 a 
Canada Health Canada http://www.hc-sc.gc.ca/fn-an/alt_formats/hpfb-dgpsa/pdf/pubs/folate-fra.pdf a 
http://www.hc-sc.gc.ca/fn-an/nutrition/prenatal/fol-qa-qr-fra.php 
a 
http://www.phac-a spc.gc.ca/fa-af/pdf/brochure_f.pdf 
b 
http://www.hc-sc.gc.ca/fn-an/alt_formats/hpfb-dgpsa/pdf/nutrition/dri_tables-eng.pdf 
a 
China E-health – Shanghai Jing’an District 
Health Promotion Board – Ministry of 
Health 
http://www.ejiankang.org/articles/12 b 
http://www.ejiankang.org/articles/5 
b 
http://www.ejiankang.org/articles/225 
a 
Chinese Nutrition Society http://www.cn soc.org/cn/nutrition.asp a 
Croatia Health Site http://zdravlje.hzjz.hr/index.php 
Ministry of Health http://www.zdravlje.hr 
Cyprus Ministry of Health http://www.moh.gov.cy/ 
Czech 
Republic 
Health Magazine http://www.magazinzdravi.cz/kyselina-listova-dokaze-snizit-riziko-porodn b 
Denmark Danish Health and Medicines Authority http://www.sst.d k/publ/Publ2010/CFF/English/SundeVaner_en.pdf b 
http://sundhedsstyrelsen.d k/da/sundhed/graviditet-og-spaedboern/anbefalinger-til-gravide/folsyre,-jern,-d-
vitamin-og-eventuelt-kalk 
b
 
Nordic Nutrition Recommendations http://www.norden.org/en/publications/publikationer/nord-2013-009 a 
Estonia National Institute for Health 
Development 
https://intra.tai.ee/images/prints/documents/130311768374_Eesti_toitumis_ja_toidusoovitused_est.pdf  
a
 
http://www.kli inikum.ee/attachments/article/522/rasedate_ja_imetavate_emade_toitumis_ja_toidusoovitused.p
df 
a 
Health Information Network http://www.terviseinfo.ee/et/component/search/? searchword=foolhape&x=-1383&y=-52&Itemid=131 b 
Treatment Guide http://www.ravijuhend.ee/ravijuhendika sutajale/patsiendijuhendid/20/Foolhape%20%E2%80%93%20mis%20j
a%20milleks? %20Foolhappe%20osat%C3%A4htsu s%20terve%20beebi%20s%C3%BCndimisel
 b 
Finland Ministry of Social Affairs and Health http://www.stm.fi/c/document_library/get_file?folderId=28707&name=DLFE-
3555.pdf&title=Lapsi__perhe_ja_ruoka_fi.pdf 
a
 
http://www.slv.se/en-gb/Startpage-NNR/NNR5 -News/A-draft-p roposal-for-NNR-20121/ 
a 
Nordic Nutrition Recommendations http://www.norden.org/en/publications/publikationer/nord-2013-009 a 
France National Institute for Prevention and 
Health Education 
http://www.inpes.sante.fr/cfesba se s/catalogue/pdf/1059.pdf 
b 
http://www.inpes.sante.fr/70000/dp/04/dp041209.pdf#xml=http://search.atomz.com/search/pdfhelper.tk?sp_o=
2,100000,0 
a 
 
National Nutrition and Health Program http://www.mangerbouger.fr/pour-qui-242/future-maman/manger-de-facon-adaptee/avant-la-grosse sse/les-
folates.html 
b 
Germany Federal Centre for Health Education – 
Family planning 
http://www.familienplanung.de/lexikon/folsaeure-prophylaxe/ 
b 
German Society for Nutrition http://www.dge.de/pdf/ws/Referenzwerte -2013-Folat.pdf a 
Greek Ministry of Health http://www.moh.gov.gr/ 
Hong Kong Department of Health http://www.fhs.gov.h k/english/health_info/files/an_5.pdf b 
The Hong Kong College of 
Obstetricians and Gynaecologist 
http://hkcog.obg.cuhk.edu.hk/docs/college_guidelines/Guidelines_on_Antenatal_Care_(Part_1)_2008.pdf a 
Hungary National Centre for Food Safety and 
Nutrition 
http://oeti.hu/download/taplalkozasi_ajanlasok_varando s_es_ szoptato_anyaknak.pdf  
a  
http://www.oeti.hu/download/kartyafolsav.pdf b 
Iceland Directorate of Health http://www.landlaeknir.is/se rvlet/file/store93/item2792/version7/3252.pdf b 
http://www.landlaeknir.is/se rvlet/file/store93/item2350/version4/2046.pdf 
a 
Nordic Nutrition Recommendations http://www.norden.org/en/publications/publikationer/nord-2013-009 a 
India Ministry of Health and Family Welfare http://mohfw.nic.in/ 
Ireland Health Service Executive http://www.h se.ie/eng/services/Publications/service s/Children/Unit_7_Food_and_Nutrition.pdf  a   
a Information for health professionals. b Information for general population. - Blank mean that any website was available/found. 
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Table a1. Web addresses and links from official health organizations websites of 46 countries worldwide and WHO (continuation).  
Country/ 
Entity 
Website Web address 
Italy Ministry of Health http://www.salute.gov.it/servizio/galleria.jsp?lang=italiano&id=543&dad=s&men=campagne07&label=genit  b 
http://www.salute.gov.it/imgs/C_17_opuscoliPoster_126_allegato.pdf a 
Japan Ministry of Health, Labour and Welfare http://www.mhlw.go.jp/shingi/2009/05/dl/s0529-4u.pdf  a 
Latvia Latvian Health Portal http://www.medicine.lv/raksti/folijskabe-g rutniecibas-laika b 
http://www.medicine.lv/raksti/gudras-uzturvielas-sievietei 
b
 
Liechtenstein Land administration http://www.llv.li/ 
Lithuania - - 
Luxemburg Ministry of Health http://www.sante.public.lu/publications/reste r-bonne-sante/alimentation/alimentation-saine-
grosse sse/alimentation-saine-grosse sse-2012-pt.pdf 
b
 
Malta Ministry for Health https://ehealth.gov.mt/HealthPortal/chief_medical_officer/healthinfor_research/registrie s/birth_defects.aspx a  
Netherlands National Institute for Public Health and 
Environment – Ministry of Health, 
Welfare and Sport 
http://toolkits.loketgezondleven.nl/toolkits/?page_id=1754#link_5487
 b 
Nutrition Centre http://www.voedingscentrum.nl/nl/mijn-kind-en-ik/zwanger/0-3-maanden-zwanger.aspx  b 
Norway National Institute of Public Health http://www.fhi.no/eway/default.aspx?pid=239&trg=Content_6496&Main_6157=6263:0:25,6269&MainContent_
6263=6496:0:25,6277&Content_6496=6178:68328::0:6276:41:::0:0&5637=6276:2  
a 
http://www.fhi.no/eway/default.aspx?pid=239&trg=List_6212&Main_6157=6263:0:25,6665&MainCon tent_6263
=6464:0:25,6667&List_6212=6218:0:25,6685:1:0:0:::0:0 a 
Nordic Nutrition Recommendations http://www.norden.org/en/publications/publikationer/nord-2013-009 a 
Poland Ministry of Health http://www.mz.gov.pl/wwwfiles/ma_stru ktura/docs/polzdrow_broszciaza_20120523zal12.pdf b 
Portugal Ministry of Health www.dgs.pt a (Circular Normativa n.º 02/DSMIA, 16-01-2006) 
http://www.plataformacontraaobesidade.dgs.pt/Resource sUse r/Institucional/Projectos%20ARS/Madeira/Alime
ntacao_Mulher.pdf 
b
 
Romania Ministry of Health – Romanian 
Nutrition Society 
http://www.ms. ro/documente/Ghid1_8318_6022.pdf 
a
 
Russia Ministry of Health of the Russian 
Federation 
https://www.ro sminzdrav.ru/docs/mzsr/analytics/2
a 
http://www.takzdorovo.ru/pitanie/zdorovoe-pitanie/folievaya-kislota
 b 
Protection and Human Welfare 75.rospotrebnadzor.ru a 
Singapore Health Promotion Board – Singapore 
Government 
http://www.hpb.gov.sg/HOPPortal/health-article/3826 
b 
http://www.hpb.gov.sg/HOPPortal/health-article/2740 
b
 
http://www.hpb.gov.sg/HOPPortal/article?id=2652 a 
Slovakia Ministry of Health http://www.health.gov.sk 
Slovenia Institute of Public Health of the 
Republic of Slovenia 
http://www.ivz.si/prehrana?pi=5&_5_Filename=attName.png&_5_MediaId=6551&_5_AutoResize=false&pl=8 -
5.3. 
a 
Ministry of Health http://www.mz.gov.si/ si/delovna_podrocja/javno_zdravje/sekto r_za_krepitev_zdravja_in_zdrav_zivljenjski_slog
/prehrana/publikacije_in_druga_gradiva/
 a 
South Africa The National Department of Health http://www.doh.gov.za/docs/policy/humangenetics.pdf a 
 
Association for Dietetics in South 
Africa 
http://www.nutritionweek.co.za/pregnancy/31food.html  
b 
South Korea Ministry of Health and Welfare http://english.mw.go.kr/f ront_eng/index.jsp 
 
Spain Ministry of Health, Social Services and 
Equality – National Health System 
http://www.msssi.gob.es/organizacion/sns/planCalidadSNS/ENSSRIntro.htm
 a 
Sweden National Food Agency http://www.slv.se/sv/g rupp1/Mat-och-naring/Kostrad/Rad-om-folsyra/ b 
http://www.slv.se/en-gb/Group1/Food-and-Nutrition/Recommendations/Advice-about-food-for-you-who-a re-
pregnant/ b 
http://www.slv.se/en-gb/Startpage-NNR/NNR5 -News/A-draft-p roposal-for-NNR-20121/ 
a 
Nordic Nutrition Recommendations http://www.norden.org/en/publications/publikationer/nord-2013-009 a 
European Food Safety Authority http://www.efsa.europa.eu/en/home/publication/folicacid2009.htm?WT.mc_id=EFSAHL01&e mt=1  
a 
Switzerland Federal Office of Public Health http://www.bag.admin.ch/themen/ernaehrung_bewegung/05207/05212/index.html?lang=fr b 
Swiss Society of Nutrition http://www.sge-ssn.ch/fr/toi-et-moi/les-denrees-alimentaires/valeurs-de-reference/#fl  a 
http://www.sge-
ssn.ch/media/medialibrary/2012/06/feuille_d_info_alimentation_de_la_femme_enceinte_2011.pdf  
a 
German Society for Nutrition http://www.dge.de/modules.php?name=Content&pa=showpage&pid=3&page=1 a 
Taiwan Health Promotion Administration – 
Ministry of Health and Welfare 
http://www.hpa.gov.tw/BHPNet/Web/HealthTopic/Topic.aspx?id=200712250002  
b 
Food and Drug Administration – 
Ministry of Health and Welfare 
https://consumer.fda.gov.tw/Pages/List.a spx?nodeID=636
a
 
https://consumer.fda.gov.tw/Files/eweekly/%E7%AC%AC213%E6%9C%9 F%E6%A0%B8%E5%AE%9A%E7
%A8%BF.doc
b 
Turkey Ministry of Health http://www.saglik.gov.tr/ 
United 
Kingdom 
National Health Service http://www.nhs.u k/conditions/pregnancy-and-baby/pages/vitamins-minerals-supplements-pregnant.aspx#close 
b
 
 
United 
States of 
America 
Centers for Disease Control and 
Prevention 
http://www.cdc.gov/ncbddd/folicacid/documents/qanda_english.pdf b 
http://www.cdc.gov/ncbddd/folicacid/recommendations.html  
a 
Institute of Medicine of the National 
Academies 
http://www.iom.edu/Activities/Nutrition/SummaryDRIs/~/media/Files/Activity%20Files/Nutrition/DRIs/New%20
Material/2_%20RDA%20and%20AI%20Values_Vitamin%20and%20Elements.pdf  
b 
Women’s health – Department of 
Health and Human Service 
http://www.womenshealth.gov/publications/our-publications/fact-sheet/folic-acid.html 
b 
World Health 
Organization 
World Health Organization http://apps.who.int/iris/bitstream/10665/77770/1/9789241501996_eng.pdf  a 
http://www.who.int/reproductivehealth/publications/maternal_perinatal_health/neural_tube_defects.pdf  
a 
a Information for health professionals. b Information for general population. - Blank mean that any website was available/found. 
